UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 10-Q

 

xQuarterly Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

 

For the quarterly period ended September 26, 2020April 3, 2021

 

¨Transition Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

 

For the transition period from                 to

 

Commission file number: 001-33346

 

Summer Infant, Inc.

(Exact name of registrant as specified in its charter)

 

Delaware20-1994619
(State or other jurisdiction(IRS Employer Identification No.)
of incorporation or organization) 

 

1275 Park East Drive 
Woonsocket, RI 02895(401) 671-6550
(Address of principal executive offices) (Zip Code)(Registrant’s telephone number, including area code)

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class Trading Symbol(s) Name of each exchange on which registered
Common Stock, par value $0.0001 SUMR Nasdaq Capital Market

 

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes x No ¨

 

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yesx No ¨

 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

 

Large accelerated filer ¨Accelerated filer ¨
Non-accelerated filer xSmaller reporting company x
 Emerging growth company ¨

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ¨

 

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ¨ No x

 

As of November 6, 2020,May 14, 2021, there were 2,131,507were 2,167,520 shares outstanding of thethe registrant’s Common Stock, $0.0001 par value per share.

 

 

 

 

 

Summer Infant, Inc.

Form 10-Q

Table of Contents

 

  Page Number
Part I.Financial Information1
   
Item 1.Condensed Consolidated Financial Statements (unaudited)1
   
 Condensed Consolidated Balance Sheets as of September 26, 2020April 3, 2021 (unaudited) and December 28, 2019January 2, 20211
   
 Condensed Consolidated Statements of Operations for the Three and Nine Months Ended September 26,April 3, 2021 and March 28, 2020 and September 28, 2019 (unaudited)2
   
 Condensed Consolidated Statements of Comprehensive Income (Loss)Loss for the Three and Nine Months Ended September 26,April 3, 2021 and March 28, 2020 and September 28, 2019 (unaudited)3
   
 Condensed Consolidated Statements of Cash Flows for the NineThree Months Ended September 26,April 3, 2021 and March 28, 2020 and September 28, 2019 (unaudited)4
   
 Condensed Consolidated Statements of Stockholder’sStockholder’ Equity for the NineThree Months Ended September 26,April 3, 2021 and March 28, 2020 and September 28, 2019 (unaudited)5
   
 Notes to Condensed Consolidated Financial Statements6
   
Item 2.Management’s Discussion and Analysis of Financial Condition and Results of Operations1718
   
Item 3.Quantitative and Qualitative Disclosures About Market Risk2223
   
Item 4.Controls and Procedures2223
   
Part II.Other Information2324
   
Item 1.Legal Proceedings2324
   
Item 1A.Risk Factors2324
   
Item 2.Unregistered Sales of Equity Securities and Use of Proceeds2324
   
Item 3.Defaults Upon Senior Securities2324
   
Item 4.Mine Safety Disclosures2325
   
Item 5.Other Information2325
   
Item 6.Exhibits2325
   
Exhibit Index2426
  
Signatures2527

 

 

 

PART I.  FINANCIAL INFORMATION

 

ITEM 1.Condensed Consolidated Financial Statements (unaudited)

 

Summer Infant, Inc. and Subsidiaries

Condensed Consolidated Balance Sheets

 

Note that all amounts presented in the table below are in thousands of U.S. dollars, except share and par value amounts.

 

 (Unaudited)     (Unaudited)    
 September 26,
2020
  December 28,
2019
  April 3,
2021
  January 2,
2021
 
ASSETS                
                
CURRENT ASSETS                
                
Cash and cash equivalents $871  $395  $447  $510 
Trade receivables, net of allowance for doubtful accounts  30,757   32,787   28,610   25,995 
Inventory, net  24,460   28,056   16,554   25,123 
Prepaid and other current assets  2,814   2,946   1,489   1,850 
TOTAL CURRENT ASSETS  58,902   64,184   47,100   53,478 
Property and equipment, net  5,205   8,788   4,494   4,789 
Other intangible assets, net  12,613   12,896   11,629   11,739 
Right to use assets, noncurrent  4,225   4,578 
Right of use assets, noncurrent  16,524   3,625 
Deferred tax assets, net  1,615   996   1,006   1,001 
Other assets  99   101   105   105 
TOTAL ASSETS $82,659  $91,543  $80,858  $74,737 
                
LIABILITIES AND STOCKHOLDERS’ EQUITY                
                
CURRENT LIABILITIES                
                
Accounts payable $29,460  $25,396  $21,618  $27,986 
Accrued expenses  7,858   7,289   6,557   6,064 
Lease liabilities, current  2,877   2,495   2,534   2,349 
Current portion of long term debt  656   875   2,321   2,125 
TOTAL CURRENT LIABILITIES  40,851   36,055   33,030   38,524 
Long-term debt, less current portion and unamortized debt issuance costs  32,130   45,359   26,401   27,536 
Lease liabilities, noncurrent  1,629   2,546   14,216   1,493 
Other liabilities     2,000   1,868   2,064 
TOTAL LIABILITIES  74,610   85,960   75,515   69,617 
                
STOCKHOLDERS’ EQUITY                
Preferred Stock, $0.0001 par value, 1,000,000 authorized, none issued or outstanding at September 26, 2020 and December 28, 2019, respectively      
Common Stock $0.0001 par value, authorized, issued and outstanding of 49,000,000, 2,161,692 and 2,131,507 at September 26, 2020 and 49,000,000, 2,138,926, and 2,108,743 at December 28, 2019, respectively  2   2 
Treasury Stock at cost (30,185 shares at September 26, 2020 and December 28, 2019)  (1,283)  (1,283)
Preferred Stock, $0.0001 par value, 1,000,000 authorized, none issued or outstanding at April 3, 2021 and January 2, 2021, respectively      
Common Stock $0.0001 par value, authorized, issued and outstanding of 49,000,000, 2,163,793 and 2,133,609 at April 3, 2021 and 49,000,000, 2,162,459, and 2,132,275 at January 2, 2021, respectively  2   2 
Treasury Stock at cost (30,184 shares at April 3, 2021 and January 2, 2021)  (1,283)  (1,283)
Additional paid-in capital  77,861   77,715   77,981   77,979 
Accumulated deficit  (66,801)  (69,088)  (69,930)  (70,190)
Accumulated other comprehensive loss  (1,730)  (1,763)  (1,427)  (1,388)
TOTAL STOCKHOLDERS’ EQUITY  8,049   5,583   5,343   5,120 
TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY $82,659  $91,543  $80,858  $74,737 

 

See notes to condensed consolidated financial statements

 


Summer Infant, Inc. and Subsidiaries

Condensed Consolidated Statements of Operations

 

Note that all amounts presented in the table below are in thousands of U.S. dollars, except share and per share amounts.

 

 (Unaudited) (Unaudited)  (Unaudited) 
 For the three months ended  For the nine months ended  For the Three Months Ended 
 September 26,
2020
  September 28,
2019
  September 26,
2020
  September 28,
2019
  April 3,
2021
  March, 28
2020
 
Net sales $40,704  $41,523  $119,256  $130,486  $36,201  $40,338 
Cost of goods sold  27,168   28,928   79,178   89,599   25,544   27,835 
Gross profit  13,536   12,595   40,078   40,887   10,657   12,503 
General & administrative expenses  6,890   8,353   21,766   26,255 
Selling expenses  2,802   3,597   9,984   10,981 
General and administrative expenses  7,027   8,147 
Selling expense  2,407   3,444 
Depreciation and amortization  783   919   2,563   2,808   560   967 
Operating income (loss)  3,061   (274)  5,765   843   663   (55)
Interest expense  1,017   1,191   3,548   3,733 
Income (loss) before (benefit) provision for income taxes  2,044   (1,465)  2,217   (2,890)
(Benefit) provision for income taxes  (166)  195   (70)  392 
Net income (loss) $2,210  $(1,660) $2,287  $(3,282)
Interest expense, net  336   1,410 
Income (loss) before income taxes  327   (1,465)
Provision (benefit) for income taxes  67   (255)
NET INCOME (LOSS) $260  $(1,210)
Net income (loss) per share:                        
BASIC $1.04  $(0.79) $1.08  $(1.56) $0.12  $(0.57)
DILUTED $1.03  $(0.79) $1.08  $(1.56) $0.12  $(0.57)
Weighted average shares outstanding:                        
BASIC  2,126,497   2,104,207   2,115,694   2,098,886   2,133,061   2,109,264 
DILUTED  2,155,791   2,104,207   2,120,044   2,098,886   2,161,789   2,109,264 

 

See notes to condensed consolidated financial statements.

 


Summer Infant, Inc. and Subsidiaries

Condensed Consolidated Statements of Comprehensive Income (Loss)Loss

 

Note that all amounts presented in the table below are in thousands of U.S. dollars.

 

 (Unaudited) 
 (Unaudited)
For the three months ended
  (Unaudited)
For the nine months ended
  For The Three Months
Ended
 
 September 26,
2020
  September 28,
2019
  September 26,
2020
  September 28,
2019
  April 3, 2021  March 28, 2020 
Net income (loss) $2,210  $(1,660) $2,287  $(3,282) $260  $(1,210)
Other comprehensive income (loss):                
Other comprehensive loss:        
Changes in foreign currency translation adjustments  40   (100)  33   113   (39)  (55)
                        
Comprehensive income (loss) $2,250  $(1,760) $2,320  $(3,169) $221  $(1,265)

 

See notes to condensed consolidated financial statements.

 


Summer Infant, Inc. and Subsidiaries

Condensed Consolidated Statements of Cash Flows

 

Note that all amounts presented in the table below are in thousands of U.S. dollars.

 

  (Unaudited) 
  For the nine months ended 
  September 26,
2020
  September 28,
2019
 
Cash flows from operating activities:        
Net income (loss) $2,287  $(3,282)
Adjustments to reconcile net income (loss) to net cash provided by operating activities:        
Depreciation and amortization  2,563   2,808 
Stock-based compensation expense  135   224 
Write off of unamortized deferred financing costs  266    
(Recovery of) provision for allowance for doubtful accounts  (14)  21 
Paid in kind interest expense  366    
Amortization of right to use asset  1,810   1,569 
Changes in assets and liabilities:        
Decrease in trade receivables  1,988   1,666 
Decrease in inventory  3,539   6,098 
Decrease in lease liability  (1,992)  (1,053)
Increase (decrease) in prepaids and other assets  178   (351)
Increase (decrease) in accounts payable and accrued expenses  4,037   (6,558)
Net cash provided by operating activities  15,163   1,142 
Cash flows from investing activities:        
Acquisitions of property and equipment  (1,052)  (1,632)
Acquisitions of other intangible assets  (83)  (281)
Net cash used in investing activities  (1,135)  (1,913)
Cash flows from financing activities:        
Issuance of common stock upon  exercise of stock options  11    
Proceeds from Paycheck Protection Program loan  1,956    
Repayment of Term Loan Facility     (656)
Net (repayment) borrowings on revolving facilities  (15,623)  1,484 
Net cash (used in) provided by financing activities  (13,656)  828 
Effect of exchange rate changes on cash and cash equivalents  104   (119)
Net increase (decrease) in cash and cash equivalents  476   (62)
Cash and cash equivalents, beginning of period  395   721 
Cash and cash equivalents, end of period $871  $659 
         
Supplemental disclosure of cash flow information:        
Cash paid for interest $2,300  $2,878 
Cash (refunded) paid for income taxes $(204) $5 
Supplemental disclosure of non-cash investing and financing activities:        
Derecognition of a building sale-leaseback fixed asset, net of depreciation $2,357  $ 
Derecognition of a building sale-leaseback financial obligation $(2,390) $ 
Right-of-use asset acquired through new operating lease $(1,457) $ 
Lease liability acquired through new operating lease $1,457  $ 
  (Unaudited) 
  For the three months ended 
  April 3,
2021
  March 28,
2020
 
Cash flows from operating activities:        
Net income (loss) $260  $(1,210)
Adjustments to reconcile net income (loss) to net cash provided by operating activities:        
Depreciation and amortization  560   967 
Stock-based compensation expense, net of forfeitures  (7)  (11)
Provision for allowance for doubtful accounts     23 
Amortization of deferred financing costs  58   182 
Write off of unamortized deferred financing costs     266 
Amortization of right of use assets  649   619 
Changes in assets and liabilities:        
(Increase) decrease in trade receivables  (2,657)  2,099 
Decrease in inventory  8,516   2,692 
Decrease of lease liability  (639)  (673)
Decrease (increase) in prepaids and other assets  386   (49)
(Decrease) increase in accounts payable and accrued expenses  (5,805)  164 
Net cash provided by operating activities  1,321   5,069 
Cash flows from investing activities:        
Acquisitions of property and equipment  (191)  (220)
Acquisitions of intangible assets     (25)
Net cash used in investing activities  (191)  (245)
Cash flows from financing activities:        
Issuance of common stock upon exercise of options  9    
Repayments of New Term Loan  (375)   
Repayments of FILO Loan  (156)   
Net repayment on financing arrangements  (662)  (4,705)
Net cash used in financing activities  (1,184)  (4,705)
Effect of exchange rate changes on cash and cash equivalents  (9)  179 
Net (decrease) increase in cash and cash equivalents  (63)  298 
Cash and cash equivalents, beginning of period  510   395 
Cash and cash equivalents, end of period $447  $693 
Supplemental disclosure of cash flow information:        
Cash paid for interest $302  $877 
Cash paid for income taxes $1  $2 
Right of use asset acquired through operating lease $13,583  $ 
Lease liability acquired through operating lease $(13,583) $ 

 

See notes to condensed consolidated financial statements.

 


Summer Infant, Inc. and Subsidiaries

Condensed Consolidated Statements of Stockholders’ Equity

(Unaudited)

 

Note that all amounts presented in the table below are in thousands of U.S. dollars, except share and per share data.

 

  Common Stock  Additional
Paid in
  Treasury  Accumulated  Accumulated
Comprehensive
  Total 
  Shares  Amount  Capital  Stock  Deficit  Loss  Equity 
Balance at December 29, 2018  2,091,178  $2  $77,396  $(1,283) $(63,885) $(2,960) $9,270 
Issuance of common stock upon vesting of restricted shares  3,681                         
Stock-based compensation          48               48 
Net loss for the period                  (1,398)      (1,398)
Foreign currency translation adjustment                      165   165 
Balance at March 30, 2019  2,094,859  $2  $77,444  $(1,283) $(65,283) $(2,795) $8,085 
Issuance of common stock upon vesting of restricted shares  8,109                         
Stock-based compensation          104               104 
Net loss for the period                  (224)      (224)
Foreign currency translation adjustment                      48   48 
Balance at June 29, 2019  2,102,968  $2  $77,548  $(1,283) $(65,507) $(2,747) $8,013 
Issuance of common stock upon vesting of restricted shares  1,640                         
Stock-based compensation          72               72 
Net loss for the period                  (1,660)      (1,660)
Foreign currency translation adjustment                      (100)  (100)
Balance at September 28, 2019  2,104,608  $2   77,620   (1,283)  (67,167)  (2,847)  6,325 
  Common Stock  Additional
Paid in
  Treasury  Accumulated  Accumulated
Comprehensive
  Total 
  Shares  Amount  Capital  Stock  Deficit  Loss  Equity 
Balance at December 28, 2019  2,108,743  $2  $77,715  $(1,283) $(69,088) $(1,763) $5,583 
Issuance of common stock
upon vesting of
restricted shares
  1,064                         
Fractional Share Issuance
upon reverse stock split
  1,620                         
Stock-based compensation, net of forfeitures          (11)              (11)
Net loss for the period                  (1,210)      (1,210)
Foreign currency
translation adjustment
                      (55)  (55)
Balance at March 28, 2020  2,111,427  $2  $77,704  $(1,283) $(70,298) $(1,818) $4,307 
Balance at January 2, 2021  2,132,275  $2  $77,979  $(1,283) $(70,190) $(1,388) $5,120 
Issuance of common stock
upon vesting of
restricted shares
  349                         
Issuance of Common Stock
upon exercise of stock
options
  985       9               9 
Stock-based compensation,
net of forfeitures
          (7)              (7)
Net income for the period                  260       260 
Foreign currency
translation adjustment
                      (39)  (39)
Balance at April 3, 2021  2,133,609  $2  $77,981  $(1,283) $(69,930) $(1,427) $5,343 

 

  Common Stock  Additional
Paid in
  Treasury  Accumulated  Accumulated
Comprehensive
  Total 
  Shares  Amount  Capital  Stock  Deficit  Loss  Equity 
Balance at December 28, 2019  2,108,743  $2  $77,715  $(1,283) $(69,088) $(1,763) $5,583 
Issuance of common stock upon vesting of restricted shares  1,064                         
Stock-based compensation          (11)              (11)
Fractional share issuance upon reverse stock split  1,620                         
Net loss for the period                  (1,210)      (1,210)
Foreign currency translation adjustment                      (55)  (55)
Balance at March 28, 2020  2,111,427  $2  $77,704  $(1,283) $(70,298) $(1,818) $4,307 
Issuance of common stock upon vesting of restricted shares  2,676                         
Stock-based compensation          42               42 
Net income for the period                  1,287       1,287 
Foreign currency translation adjustment                      48   48 
Balance at June 27, 2020  2,114,103  $2  $77,746  $(1,283) $(69,011) $(1,770) $5,684 
Issuance of common stock upon vesting of restricted shares  16,014                         
Issuance of common stock upon exercise of stock options  1,390       11               11 
Stock-based compensation          104               104 
Net income for the period                  2,210       2,210 
Foreign currency translation adjustment                      40   40 
Balance at September 26, 2020  2,131,507  $2   77,861   (1,283)  (66,801)  (1,730)  8,049 

See notes to condensed consolidated financial statements.

 


SUMMER INFANT, INC.  AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

 

1.BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

 

Nature of Operations

 

The Company designs, markets and distributes branded juvenile health, safety and wellnessconvenience products that are sold globally to large national retailers as well as independent retailers, primarily in North America. The Company currently markets its products in several product categories including monitoring, safety, nursery, monitoring, and baby gear. Most products are sold under our core brand names of Summer™, and SwaddleMe®, and born freeTM. When used herein, the terms the “Company,” “we,” “us,” and “our” mean Summer Infant, Inc. and its consolidated subsidiaries.

 

Basis of Presentation and Principles of Consolidation

 

The accompanying interim condensed consolidated financial statements of the Company are unaudited, but in the opinion of management, reflect all adjustments, consisting of normal recurring accruals, necessary for a fair presentation of the results for the interim periods. Accordingly, they do not include all information and notes required by generally accepted accounting principles in the United States of America (“GAAP”) for complete financial statements. The results of operations for interim periods are not necessarily indicative of results to be expected for the entire fiscal year or any other period. The balance sheet at December 28, 2019January 2, 2021 has been derived from the audited financial statements at that date but does not include all of the information and footnotes required by GAAP for complete financial statements. These interim condensed consolidated financial statements should be read in conjunction with the Company’s consolidated financial statements and notes for the year ended December 28, 2019January 2, 2021 included in its Annual Report on Form 10-K filed with the SEC on March 18, 2020, as amended on April 24, 2020.16, 2021.

 

It is the Company’s policy to prepare its financial statements on the accrual basis of accounting in conformity with GAAP. The interim condensed consolidated financial statements include the accounts of its wholly-owned subsidiaries. All significant intercompany accounts and transactions have been eliminated in the consolidation.

 

All dollar amounts included in the Notes to Condensed Consolidated Financial Statements are in thousands of U.S. dollars, except share and per share amounts.

 

In March 2020, the Company completed a 1-for-9 reverse stock split of the Company's issued and outstanding shares of common stock in order to regain compliance with Nasdaq's minimum bid price requirement. Accordingly, all information in the financial statements and accompanying notes included within this Quarterly Report on Form 10-Q have been adjusted retrospectively to give effect to the reverse stock split as if it occurred at the beginning of the first period presented.

 

Reclassification

 

Previously reported amounts have been revised in the accompanying condensed consolidated statement of cash flows to properly state certain right to use assets and lease liabilities.the 2020 amortization of deferred financing costs. These revisions had no impact onincreased the Company’s net cash provided by operating activities.activities and decreased the Company’s net cash provided by financing activities by $182. Net decrease in cash and cash equivalents remained unchanged.

 

Revenue Recognition

 

The Company recognizesapplies FASB ASC Topic 606, Revenue from Contracts with Customers (“ASC 606”). The guidance sets forth a five-step revenue recognition model and is intended to eliminate numerous industry-specific pieces of revenue recognition guidance that have historically existed in U.S. GAAP. The underlying principle of the standard is that a business or other organization will recognize revenue to depict the transfer of promised goods or services to customers in an amount that reflects what it expects to receive in exchange for the goods.goods or services.

 


The Company’s principal activities from which it generates its revenue is product sales. The Company has one reportable segment of business.

 

Revenue is measured based on consideration specified in a contract with a customer. The Company recognizes revenue when it satisfies a performance obligation in a contract by transferring control over a product to a customer when product delivery occurs. Consideration is typically paid approximately 60 days from the time control is transferred. Taxes assessed by a governmental authority that are both imposed on and concurrent with a specific revenue-producing transaction, that are collected by the Company from a customer, are excluded from revenue. Shipping and handling costs associated with outbound freight after control over a product has transferred to a customer are accounted for as a fulfillment cost and are included in selling costs.

 

A performance obligation is a promise in a contract to transfer a distinct product to the customer, which for the Company is transfer of primarily juvenile products to its customers. The transaction price of a contract is allocated to each distinct performance obligation and recognized as revenue when or as the customer receives the benefit of the performance obligation.


A transaction price is the amount of consideration the Company expects to receive under the arrangement. The Company is required to estimate variable consideration (if any) and to factor that estimation into the determination of the transaction price. The Company conducts its business with customers through valid purchase or sales orders each of which is considered a separate contract because individual orders are not interdependent on one another. Product transaction prices on a purchase or sale order are discrete and stand-alone. Purchase or sales orders may be issued under either a customer master service agreement or a reseller allowance agreement. Purchase or sales orders, master service agreements, and reseller allowance agreements, which are specific and unique to each customer, may include product price discounts, markdown allowances, return allowances, and/or volume rebates which reduce the consideration due from customers. Variable consideration is estimated using the most likely amount method, which is based on historical experience as well as current information such as sales forecasts.

 


Contracts may also include cooperative advertising arrangements where the Company allows a discount from invoiced product amounts in exchange for customer purchased advertising that features the Company’s products. These allowances are generally based upon product purchases or specific advertising campaigns. Such allowances are accrued when the related revenue is recognized. These cooperative advertising arrangements provide a distinct benefit and fair value and are accounted for as direct selling expenses.

 

Use of Estimates

 

The preparation of financial statements in accordance with GAAP requires management to make estimates and assumptions that affect certain reported amounts of revenues, expenses, assets, liabilities and related disclosures. These estimates are based on management’s best knowledge as of the date the financial statements are published of current events and actions the Company may undertake in the future.  Accordingly, actual results could differ from those estimates.

 

Cash and Cash Equivalents

Cash flows, cash and cash equivalents include money market accounts and investments with an original maturity of three months or less. At times, the Company possesses cash balances in excess of federally-insured limits.

Trade Receivables

 

Trade receivables are carried at their outstanding unpaid principal balances reduced by an allowance for doubtful accounts. The Company estimates doubtful accounts based on historical bad debts, factors related to specific customers’ ability to pay and current economic trends. The Company writes off accounts receivable against the allowance when a balance is determined to be uncollectible. Amounts are considered to be uncollectable based upon historical experience and management’s evaluation of outstanding accounts receivable.

 

Changes in the allowance for doubtful accounts are as follows:

 

 For the
Nine months ended
  For the
three months ended
 
 September 
26, 2020
  September 
28, 2019
  April 3, 2021  March 28, 2020 
Allowance for doubtful accounts, beginning of period $542  $304  $197  $542 
(Reversals of) charges to costs and expenses, net  (14)  21 
Charges to costs and expenses, net  6   23 
Account write-offs  (222)         
Allowance for doubtful accounts, end of period $306  $325  $203  $565 

 

Inventory Valuation

 

Inventory is comprised mostly of finished goods and some component parts and is stated at the lower of cost using the first-in, first-out (“FIFO”) method, or net realizable value. The Company regularly reviews slow-moving and excess inventories and writes down inventories to net realizable value if the expected net proceeds from the disposals of excess inventory are less than the carrying cost of the merchandise.

 

Leases

 

The Company determines if an arrangement is a lease at inception. Operating leases are included in operating lease right-of-use (“ROU”) assets and operating lease liabilities in the Company’s condensed consolidated balance sheets.

 


ROU assets represent the Company’s right to use an underlying asset for the lease term and lease liabilities represent the Company’s obligation to make lease payments arising from the lease. Operating lease ROU assets and liabilities are recognized at commencement date based on the present value of lease payments over the lease term. As the Company’s leases do not provide an implicit rate, the Company’s uses its incremental borrowing rate based on the information available at commencement date in determining the present value of lease payments. The operating lease ROU asset also includes any lease payments made and excludes lease incentives. The Company’s lease terms may include options to extend or terminate the lease when it is reasonably certain that the Company will exercise that option.

 


The components of a lease should be split into three categories: lease components (e.g., land, building, etc.), non-lease components (e.g., common area maintenance, maintenance, consumables, etc.), and non-components (e.g., property taxes, insurance, etc.). Then the fixed and in-substance fixed contract consideration (including any related to non-components) must be allocated based on fair values to the lease components and non-lease components. Although separation of lease and non-lease components is required, certain practical expedients are available to entities. Entities electing the practical expedient would not separate lease and non-lease components. Rather, they would account for each lease component and the related non-lease component together as a single component. The Company’s facilities operating leases have lease and non-lease components to which the Company has elected to apply the practical expedient and account for each lease component and related non-lease component as one single component. The lease component results in a ROU asset being recorded on the balance sheet. Lease expense for lease payments is recognized on a straight-line basis over the lease term.

 


Income Taxes

 

Income taxes are computed using the asset and liability method of accounting. Under the asset and liability method, a deferred income tax asset or liability is recognized for estimated future tax effects attributable to temporary differences and carry-forwards. The measurement of deferred income tax assets is adjusted by a valuation allowance, if necessary, to recognize future tax benefits only to the extent, based on available evidence, that it is more likely than not that such benefits will be realized. The net deferred tax assets and liabilities are presented as noncurrent.

 

The Company utilized the discretefull year forecast method of accounting for income taxes in the U.S. for the three and nine months ended September 26, 2020April 3, 2021 and utilized the discrete method for the three and nine months ended SeptemberMarch 28, 20192020 as it believes the discrete method results in a more accurate representation of the income tax provisionbenefit for the periods.quarter in 2020.

 

The Company follows the appropriate guidance relative to uncertain tax positions. This standard provides detailed guidance for the financial statement recognition, measurement and disclosure of uncertain tax positions recognized in the financial statements. Uncertain tax positions must meet a recognition threshold of more-likely-than-not in order for those tax positions to be recognized in the financial statements.

 

On March 27, 2020, the U.S. CARES Act was enacted, which provided a substantial tax-and-spending package intended to provide additional economic stimulus to address the impact of the COVID-19 pandemic. The U.S. CARES Act provides numerous tax provisions and other stimulus measures, including temporary changes regarding the prior and future utilization of net operating losses, temporary changes to the prior and future limitations on interest deductions, temporary suspension of certain payment requirements for the employer portion of Social Security taxes, technical corrections from prior tax legislation for tax depreciation of certain qualified improvement property, and the creation of certain refundable employee retention credits. AsFor the three months ended March 28, 2020 and as a result of the U.S. CARES Act tax law changes, and revised final regulations released on July 28, 2020, we recognized a $624$262 tax benefit for the nine months ended September 26, 2020 related to the increase in interest deduction occurring during the fiscal yearsyear ended December 28, 2019 and December 29, 2018 which was previously fully reserved for. No discrete items are being recognized for the three months ended April 3, 2021. The impacttax rate for the three months ended April 3, 2021 includes an expected decrease in valuation allowance of $262 for the U.S. CARES Act in prospective periods may differutilization of nondeductible interest expense from our estimate asprior years. As of September 26, 2020 due to changes in interpretationsyear ended January 2, 2021 and assumptions, additional guidance that may be issued and actionsquarter ended April 3, 2021, the Company may take in response to the U.S. CARES Act. The U.S. CARES Act is highly detailed, and the Company will continue to assess the impact that various provisions will have on its business.has uncertain tax positions of $7,543.

 

Net Loss/IncomeIncome/Loss Per Share

 

Basic income or loss per share for the Company is computed by dividing net income or loss by the weighted-average number of shares of common stock outstanding during the period. Diluted income or loss per share includes the dilutive impact of outstanding stock options and unvested restricted shares.

 

Translation of Foreign Currencies

 

Assets and liabilities of the Company’s foreign subsidiaries whose functional currency is its local currency, are translated into U.S. dollars at the exchange rate in effect at the end of the quarter and the income and expense accounts of these affiliates have been translated at average rates prevailing during each respective quarter. Resulting translation adjustments are made to a separate component of stockholders’ equity within accumulated other comprehensive loss. Assets and liabilities of the Company’s foreign subsidiaries whose functional currency is the U.S. dollar are remeasured into U.S. dollars at their historical rates or the exchange rate in effect at the end of the quarter and the income and expense accounts of these affiliates have been remeasured at average rates prevailing during each respective quarter. Resulting remeasurement adjustments are made to the condensed consolidated statement of operations. Foreign exchange transaction gains and losses are included in the accompanying interim, condensed consolidated statement of operations.

 


20202021 Plan and COVID-19 Pandemic

 

In MarchThe Company believes that its existing plan will generate sufficient cash which, along with its existing cash and availability under its facilities, will enable it to fund operations through at least the next 12 months. However, should the Company require additional cash, or should the impact from the COVID-19 pandemic discussed below be more severe than expected, the Company would identify other cost reductions or seek additional resources.  Beginning in the first quarter of 2020, the COVID-19 outbreak was declared a global pandemic and became widespreadnegatively impacted the macroeconomic environment in the U.S. United States and globally, and the Company’s business.

While our products are considered “essential” and our distribution center located in California continues to operate, some of our customers have been impacted and to the extent they operated retail stores,we have been required to close their stores and curtail operations. We beganmay continue to see ansupply chain disruption.  The ultimate impact of the COVID-19 pandemic will depend on orders atnumerous evolving factors that the end of MarchCompany may not be able to accurately predict, including the duration and have continued to see lower demand from our mid-sized and smaller customers as governmental restrictions on businesses remain in place and with the resurgence of COVID-19. Due to the uncertainty with respect to when governmental restrictions may be lifted and the widespread natureextent of the pandemic, we cannot currently predict how it willthe impact our businessof federal, state, local and foreign governmental actions, consumer behavior in response to the long term.  pandemic and other economic and operational conditions the Company may face.

The Company is not currently aware of any events or circumstances arising from the COVID-19 pandemic that would require us to update any estimates, judgments or materially revise the carrying value of our assets or liabilities. The Company’s estimates may change, however, as events evolve and additional information is obtained, and any such changes will be recognized in the condensed consolidated financial statements.

 

Beginning in the first quarter of 2020, the Company implemented various restructuring initiatives to streamline operations and support its liquidity needs, including headcount reductions, reductions in facility space, and other cost reductions, as well as working with its lenders to amend its credit facility and term loan agreement to undertake these restructuring initiatives and to provide availability.  In addition, the Company began taking actions to mitigate the impact of the expiration in August 2020 of tariff exclusions previously granted with respect to certain of its products, including seeking price increases from its customers and alternative manufacturing sources.  In light of the ongoing uncertainty surrounding the COVID-19 pandemic in the U.S. and other countries and unpredictable economic consequences in the coming months, the Company applied for and in August 2020, received a loan through the Paycheck Protection Program of the U.S. CARES Act in the amount of $1,956, which may be used to fund certain qualified expenses, including payroll costs, rent and utility costs. Further, as noted in Note 9, after the end of the third quarter the Company refinanced its existing debt. The Company believes that its existing plan will generate sufficient cash which, along with its existing cash and availability under its facilities, will enable it to fund operations through at least the next 12 months. To the extent the Company experiences unexpected impacts from the COVID-19 pandemic or is unable to meet its current financial forecast, the Company would take further action to reduce costs, mitigate risks to its supply chain and, if necessary, seek to raise additional funds through debt or equity financings, engage in strategic collaborations, and/or a strategic transaction.

2.REVENUE RECOGNITION

2.REVENUE

 

Disaggregation of Revenue

 

The Company’s revenue is primarily from distinct fixed-price product sales in the juvenile product market, to similar customers and channels utilizing similar types of contracts that are short term in nature (less than one year). The Company does not sell service agreements or goods over a period of time and does not sell or utilize customer financing arrangements or time-and-material contracts.

 

The following is a table that presents net sales by geographical area:

 

 For the Three
Months Ended
 For the Three
Months Ended
  For the
three months ended
 
 September 26, 2020 September 28, 2019  April 3, 2021  March 28, 2020 
United States $35,729  $35,833  $33,096  $35,778 
All Other  4,975   5,690   3,105   4,560 
Net Sales $40,704  $41,523  $36,201  $40,338 

 

  For the nine
months ended
September 26, 2020
  For the nine
months ended
September 28, 2019
 
United States $107,307  $111,133 
All Other  11,949   19,353 
Net Sales $119,256  $130,486 


All Other consists of Canada, Europe, South America, Mexico, Asia, and the Middle East.

 

Contract Balances

 

The Company does not have any contract assets such as work-in-process or contract liabilities such as customer advances. All trade receivables on the Company’s condensed consolidated balance sheetsheets are from contracts with customers.

 

Contract Costs

 

Costs incurred to obtain a contract are capitalized unless short term in nature. As a practical expedient, costs to obtain a contract that are short term in nature are expensed as incurred. All contract costs incurred in the three and nine months ended September 26, 2020April 3, 2021 and three and nine months ended SeptemberMarch 28, 20192020 fall under the provisions of the practical expedient and have therefore been expensed.

 

3.DEBT


3.DEBT

 

Credit FacilitiesLoan Agreement with Bank of America.

 

On October 15, 2020, the Company and its wholly owned subsidiary, Summer Infant (USA), Inc., as borrowers, entered intobecame parties to a Third Amended and Restated Loan and Security Agreement (the “Third Restated BofA“Loan Agreement”) with Bank of America, N.A. (“BofA”), as agent, that provides for (i) a $40,000 asset-based revolving credit facility, with a $5,000 unused letter of credit sub-line facility, (ii) a $7,500 term loan and (iii) a $2,500 FILO (first-in, last-out) loan. The Loan Agreement replaced its existingthe Company’s prior agreement with BofA and funded in part the prepayment of the Company’s outstanding term loan with Pathlight Capital LLC, increased revolver and lowered itsCapital. Subsequent to quarter end, we entered into a letter agreement with BofA regarding certain eligible accounts as described below.

Pursuant to the Loan Agreement, total borrowing capacity under the revolving credit facility is based on a borrowing base, which is generally defined as 85% of eligible receivables plus the lesser of (i) 70% of the value of eligible inventory (subject to certain limitations) or (ii) 85% of the net orderly liquidation value of eligible inventory, less applicable reserves. The scheduled maturity date of the loans under the revolving credit facility is October 15, 2025 (subject to customary early termination provisions). Loans under the revolving credit facility bear interest, rates. Information about the Third Restated BofA Agreement is included below in Note 9. The following description of debt reflectsat the Company’s agreements that were effectiveoption, at a base rate or at LIBOR, plus applicable margins based on average quarterly availability. Interest payments are due monthly, payable in arrears. The Company is also required to pay an annual non-use fee on unused amounts under the revolving credit facility, as well as other customary fees as are set forth in the Loan Agreement. As of April 3, 2021, the interest rate was 2.625% on LIBOR based revolver loans. At April 3, 2021, the amount outstanding on the revolving credit facility was $20,805, the total borrowing base was $28,174, and borrowing availability was $7,369.

The principal of the term loan is to be repaid, on a quarterly basis, in installments of $375, until paid in full on termination and subject to mandatory repayment in certain circumstances. The scheduled maturity date of the term loan is October 15, 2025 or earlier, if the revolving credit facility is terminated. The term loan bears interest, at the Company’s option, at a base rate or at LIBOR, plus applicable margins, and interest payments are due monthly, in arrears. As of April 3, 2021, the interest rate on LIBOR based term loans and on base rate term loans was 3.875% and 5.750%, respectively. The amount outstanding on the term loan was $6,750 as of September 26, 2020.April 3, 2021.

 

The total borrowing capacity under the FILO loan is the lesser of (i) the then applicable aggregate FILO commitment amount and (ii) a borrowing base, generally defined as a specific percentage of the value of eligible accounts, plus a specified percentage of the value of eligible inventory. The aggregate FILO commitment amount as of April 3, 2021 was $2,188 with no further availability, and such amount will be proportionately reduced each quarter until the FILO loan is terminated at maturity on October 15, 2024. There can be no voluntary repayment on the FILO loan as long as there are loans outstanding under the revolving credit facility, unless (i) there is an overadvance under the FILO loan, or (ii) such prepayment is accompanied by a permanent dollar for dollar reduction in the aggregate FILO commitment amount such that, after giving effect to such prepayment and reduction, the outstanding principal amount of the FILO loan is equal to but does not exceed the lesser of (A) the aggregate FILO commitment amount and (B) the FILO borrowing base. The FILO loan bears interest, at the Company’s option, at a base rate or at LIBOR, plus applicable margins, and interest payments are due monthly, in arrears. As of April 3, 2021, the interest rate on the LIBOR based FILO loans and on base rate FILO loans was 3.625% and 5.500%, respectively.

All obligations under the Loan Agreement are secured by substantially all the assets of the Company, and the Company’s subsidiaries, Summer Infant Canada Limited and Summer Infant Europe Limited, are guarantors under the Loan Agreement. The Loan Agreement contains customary affirmative and negative covenants. Among other restrictions, the Company is restricted in its ability to incur additional debt, make acquisitions or investments, dispose of assets, or make distributions unless in each case certain conditions are satisfied. Until the term loan and FILO loan have been repaid in full, the Company must maintain a fixed charge coverage ratio at the end of each fiscal month of at least 1.00 to 1.00 for the twelve-month period then ended. After the term loan and FILO loan have been repaid in full, the Company will be required to maintain the fixed charge coverage ratio if availability falls below $5,000.


The Loan Agreement also contains customary events of default, including if the Company fails to comply with any required financial covenants, if there is an event of default under the PPP Loan (described below) and the occurrence of a change of control. In the event of a default, all of the obligations under the Loan Agreement may be declared immediately due and payable. For certain events of default relating to insolvency and receivership, all outstanding obligations become due and payable.

On April 16, 2021, the Company, Summer Infant (USA), Inc., as borrowers, and certain subsidiaries of the Company as guarantors, entered into a letter agreement with BofA with respect to the Loan Agreement pursuant to which the maximum percentage of accounts owing from Wal-Mart that may be included in eligible accounts under the Loan Agreement was increased from 35% to 45%, effective from March 31, 2021 through July 31, 2021.

Prior Bank of America Credit Facility. On June 28, 2018, the Company and Summer Infant (USA), Inc., as borrowers, entered into a Second Amended and Restated Loan and Security Agreement with Bank of America, N.A., as agent, the financial institutions party to the agreement from time to time as lenders, and certain subsidiaries of the Company as guarantors as amended through August 2020 (as amended, the “Restated“Prior BofA Agreement”). The RestatedPrior BofA Agreement replaced the Company’s prior credit facility with Bank of America, and provided for an asset-based revolving credit facility, with a $5,000 letter of credit sub-line facility. As of September 26, 2020, total revolver commitments under the credit facility were $48,000. The total borrowing capacity as of September 26, 2020 was based on a borrowing base, which was defined as 85% of eligible receivables plus the lesser of (i) 70% of the value of eligible inventory or (ii) 85% of the net orderly liquidation value of eligible inventory, less applicable reserves. The scheduled maturity date of loans under the RestatedPrior BofA Agreement was June 28, 2023 (subject to customary early termination provisions). As a result ofOn October 15, 2020, the amendments made to the RestatedPrior BofA Agreement inwas replaced by the first nine months of 2020, (i) the definition of Financial Covenant Trigger Amount was modified, (ii) the lenders' aggregate revolver commitments were reduced to $48,000, (iii) the definition of EBITDA was amended to exclude certain fees and expenses, (iv) the Company was required to meet certain minimum net sales amounts for each period of three consecutive fiscal months through the three-month period ending December 31, 2020, (v) the Company was required to meet a certain minimum EBITDA (as defined in the Restated BofA Agreement) as of the end of each fiscal month, calculated on a trailing 12-month basis, (vi) the applicable margin and applicable unused line fee rate were increased, (vii) a LIBOR floor of 0.75% was added, (viii) certain reporting requirements were modified, (ix) the maximum percentage of accounts owing from the Amazon Companies that could be included as eligible accounts was temporarily increased and (x) certain provisions were modified to accommodate the PPP Loan Agreement described below.

All obligations under the Restated BofA Agreement were secured by substantially all the assets of the Company, including a first priority lien on accounts receivable and inventory and a junior lien on certain assets subject to the Term Loan lender’s first priority lien described below. Summer Infant Canada Limited and Summer Infant Europe Limited, subsidiaries of the Company, were guarantors under the Restated BofA Agreement. Proceeds from the loans were used to satisfy existing debt, pay fees and transaction expenses associated with the closing of the Restated BofA Agreement and could be used to pay obligations under the Restated BofA Agreement, and for lawful corporate purposes, including working capital.

above. Loans under the RestatedPrior BofA Agreement bore interest, at the Company’s option, at a base rate or at LIBOR, plus applicable margins based on average quarterly availability under the RestatedPrior BofA Agreement. Interest payments were due monthly, payable in arrears. The Company was also required to pay an annual non-use fee on unused amounts, as well as other customary fees as are set forth in the Restated BofA Agreement. The Restated BofA Agreement contained customary affirmative and negative covenants. Among other restrictions, the Company was restricted in its ability to incur additional debt, make acquisitions or investments, dispose of assets, or make distributions unless in each case certain conditions were satisfied. The Company was also required to meet certain financial covenants through the end of fiscal 2020, specifically (a) a minimum net sales amount for each period of three consecutive fiscal months, measured at the end of each month, and (b) a trailing, 12-month minimum adjusted EBITDA amount (as defined in the Restated BofA Agreement), measured at the end of each fiscal month. In addition, if availability fell below agreed minimum amounts, a springing covenant would have been in effect requiring the Company to maintain a fixed charge coverage ratio at the end of each fiscal month of at least 1.0 to 1.0 for the twelve-month period then ended.


The Restated BofA Agreement also contained customary events of default, including a cross default with the Term Loan Agreement described below or the occurrence of a change of control. In the event of a default, the lenders could declare all of the obligations of the Company and its subsidiaries under the Restated BofA Agreement immediately due and payable. For events of default relating to insolvency and receivership, all outstanding obligations automatically would have become due and payable without any action on the part of the lenders.

As of September 26, 2020, under the Restated BofA Agreement, the rate on base-rate loans was 5.75% and the rate on LIBOR-rate loans was 4.25%. The amount outstanding on the Restated BofA Agreement at September 26, 2020, was $16,255 and borrowing availability was $15,924.

The amendments executed in the nine months ended September 26, 2020 were evaluated to determine the proper accounting treatment for the transactions. Accordingly, debt extinguishment accounting was used to account for the reduction in the total revolver commitments under the credit facility, resulting in the write off of $266 in remaining unamortized deferred financing costs during the three months ended March 28, 2020.

 

Prior Term Loan Agreement.On June 28, 2018, the Company and Summer Infant (USA), Inc., as borrowers, entered into a Term Loan and Security Agreement (as amended, the “Term Loan Agreement”) with Pathlight Capital LLC, as agent, each lender from time to time a party thereto,to the Term Loan Agreement, and certain subsidiaries of the Company as guarantors, as amended through August 2020 (as amended, the “Term Loan Agreement”) that providedproviding for a $17,500 term loan (the “Term Loan”). Proceeds from the Term Loan were used to satisfy existing debt, pay fees and transaction expenses associated with the closing of the Term Loan and could be used to pay obligations under the Term Loan Agreement, and for lawful corporate purposes, including working capital. The Term Loan was secured by a lien on certain assets of the Company, including a first priority lien on intellectual property, machinery and equipment, and a pledge of (i) 100% of the ownership interests of domestic subsidiaries and (ii) 65% of the ownership interests in certain foreign subsidiaries of the Company, and a junior lien on certain assets subject to the liens under the Restated BofA Agreement described above. The Term Loan had a maturity date of June 28, 2023. Summer Infant Canada Limited and Summer Infant Europe Limited, subsidiaries of the Company, were guarantors under the Term Loan Agreement. As a result of the amendments made to the Term Loan Agreement in the first nine months of 2020, (i) the definition of IP Advance Rate Reduction was modified, (ii) the definition of Term Loan Borrowing Base was modified to deduct a specified equipment reserve amount from the calculation of the borrowing base, (iii) the definitions of Financial Covenant Trigger Amount and EBITDA were amended consistent with the Restated BofA Agreement, (iv) consistent with the Restated BofA Agreement, the Company was required to meet certain minimum net sales amounts for each period of three consecutive fiscal months through the three-month period ending December 31, 2020 and certain minimum EBITDA as of the end of each fiscal month, calculated on a trailing 12-month period, (v) principal payments on the term loan were suspended for 2020 and such payments were to resume in March 2021, (vi) a LIBOR floor of 0.75% was added, (vii) certain reporting requirements were modified, and (viii) certain provisions were modified to accommodate the PPP Loan described below. In addition, as described below, beginning March 10, 2020, the Term Loan began to bear additional interest, to be paid in kind ("PIK interest") at an annual rate of 4.0%.

 

The principal of the Term Loan was to bebeing repaid, on a quarterly basis, in installments of $219, with the first installment having been paid on December 1, 2018, until paid in full on termination. Intermination, provided that, in connection with the March 2020 amendment, principal payments on the Term Loan were suspended for 2020 and wereamendments to resume in March 2021. The Term Loan bore interest at an annual rate equal to LIBOR, plus 9.0%. Cash interest payments were due monthly, in arrears. In addition, the Term Loan began to accrue PIK (payment in kind) interest at an annual rate of 4.0% in March 2020, which interest would become payable upon the earlier to occur of (i) the repayment of the Term Loan in full, (ii) a sale or merger of the Company, (iii) the occurrence of default or event of default under the Term Loan Agreement, or (iv) the Company achieving adjusted EBITDA of $12 million (calculated on a trailing, 12-month basis). If,principal payments for March, June and only if, the PIK interest became due and payable as a result of the Company achieving the adjusted EBITDA event noted in clause (iv), then the Company was required to pay all PIK interest then due and thereafter, PIK interest would continue to accrue and be paid on each subsequent anniversary of such event. Obligations under the Term Loan AgreementSeptember 2020 were also subject to a prepayment penalty if thesuspended. The Term Loan was repaid prior to the third anniversary of the closing of the Term Loan.


The Term Loan Agreement contained customary affirmative and negative covenants that were substantially the same as the Restated BofA Agreement. Consistent with the Restated BofA Agreement, the Company was also required to meet certain financial covenants through the end of fiscal 2020, specifically (a) a minimum net sales amount for each period of three consecutive fiscal months, measured at the end of each month, and (b) a trailing, 12-month minimum adjusted EBITDA amount (as defined in the Restated BofA Agreement), measured at the end of each fiscal month. In addition, consistent with the Restated BofA Agreement, if availability fell below a specified amount as described above, then the Company was required to maintain a fixed charge coverage ratio at the end of each fiscal month of at least 1.0 to 1.0 for the twelve-month period then ended. The Term Loan Agreement also contained events of default, including a cross default with the Restated BofA Agreement or the occurrence of a change of control. In the event of a default, the lenders could declare all of the obligations of the Company and its subsidiaries under the Term Loan Agreement immediately due and payable. For events of default relating to insolvency and receivership, all outstanding obligations automatically become due and payable without any actionfull on the part of the lenders.October 15, 2020.

 

As of September 26, 2020, the interest rate on the Term Loan was 9.75% of cash interest and 4.0% of PIK interest. The amount outstanding on the Term Loan at September 26, 2020 was $16,406 and $366 of accrued PIK interest.

Aggregate maturities of bank debt related to the Restated BofA Agreement and the Term Loan Agreement including PIK interest as of September 26, 2020 was as follows:

Fiscal Year ending:    
2020    
2021   875 
2022   875 
2023 and thereafter  $31,277 
Total  $33,027 

Unamortized debt issuance costs were $2,197 at September 26, 2020 and $2,398 at December 28, 2019, and are presented as a direct deduction of long-term debt on the condensed consolidated balance sheets.

PPP Loan.

 

On August 3, 2020, the Company received loan proceeds of $1,956 (the “PPP Loan”) pursuant to the Paycheck Protection Program (“PPP”) administered by the U.S. Small Business Administration under the U.S. CARES Act. The PPP Loan, which was in the form of a promissory note (the “PPP Note”), between the Company and BofA, as the lender, matures on July 27, 2025 and bears interest at a fixed rate of 1% per annum, payable monthly commencing sixannum. Monthly principal and interest payments are deferred until (i) the date on which the amount of forgiveness is remitted to the Company’s lender, (ii) the date on which the Company’s lender provides notice that the Company is not entitled to loan forgiveness, and (iii) if a borrower does not apply for loan forgiveness, 10 months fromafter the date of the PPP Loan.loan forgiveness covered period. The Company may voluntarily prepay the borrowings in full with no associated penalty or premium. Under the terms of the PPP, the principal and interest may be forgiven if the PPP Loan proceeds are used for qualifying expenses, including payroll costs, rent and utility costs. There is no guaranty that all or a portion of this loan will be forgiven. The PPP Note contains customary representations, warranties, and covenants for this type of transaction, including customary events of default relating to, among other things, payment defaults and breaches of representations and warranties or other provisions of the PPP Note. The occurrence of an event of default may result in, among other things, the Company becoming obligated to repay all amounts outstanding under the PPP Note. The PPP Loan balance of $1,956 of which $1,760 is included in Other liabilities and $196 is included in the Current portion of long-term debt on the consolidated balance sheet. On February 18, 2021, the Company applied for full forgiveness of the PPP loan through Bank of America. Bank of America has since reviewed the application and supporting documentation and they have forwarded the application to the Small Business Administration (“SBA”) for its review.

 

4.        PROPERTY AND EQUIPMENTAggregate maturities of bank debt related to the Loan Agreement and the PPP Loan are as follows:

 

Property and equipment, at cost, consisted of the following:

    Depreciation/ 
  September 26, 2020  December 28, 2019  Amortization Period 
Computer-related  4,532  $4,511   5 years 
Tools, dies, prototypes, and molds  27,662   27,457   1 - 5 years 
Building     4,156   30 years 
Other  7,650   7,474   1 - 15 years 
   39,844   43,598     
Less: accumulated depreciation  34,639   34,810     
Property and equipment, net $5,205  $8,788     
Fiscal Year ending:   
2021  1,692 
2022  1,985 
2023  2,516 
2024  2,516 
2025 and beyond  22,990 
Total $31,699 

 

PropertyUnamortized debt issuance costs were $1,217 at April 3, 2021 and equipment included amounts acquired under capital leases$1,275 at January 2, 2021, and are presented as a direct deduction of approximately $589 and $589 at September 26, 2020 and December 28, 2019, respectively, with related accumulated depreciation of approximately $189 and $115, respectively. Total depreciation expense was $2,197 and $2,254 for the nine months ended September 26, 2020 and September 28, 2019, respectively.


See Note 6long-term debt on the derecognition of the building asset in May 2020.consolidated balance sheets.

 

5.4.INTANGIBLE ASSETS

 

Intangible assets consisted of the following:

 

 September 26, 2020  December 28, 2019  April  3, 2021 January 2, 2021 
Brand names $11,819  $11,819  $10,900  $10,900 
Patents and licenses  4,184   4,101   4,125   4,125 
Customer relationships  6,946   6,946   6,946   6,946 
Other intangibles  1,882   1,882   1,882   1,882 
  24,831   24,748   23,853   23,853 
Less: Accumulated amortization  (12,218)  (11,852)  (12,224)  (12,114)
Intangible assets, net $12,613  $12,896  $11,629  $11,739 

 


The amortization period for the majority of the intangible assets ranges from 5 to 20 years for those assets that have an estimated life; certain of the assets have indefinite lives (brand names). Amortization expense for the nine months ended September 26, 2020 and September 28, 2019 was $366 and $554, respectively. Total of intangibles not subject to amortization amounted to $8,400 as of September 26, 2020April 3, 2021 and September 28, 2019.

January 2, 2021.

 

6.5.COMMITMENTS AND CONTINGENCIES

 

Leases

 

The Company leases office space and distribution centers primarily related to its United States, Canada, United Kingdom, and Hong Kong operations. In connection with these leases, there were no cash incentives from the landlord to be used for the construction of leasehold improvements within the facility.

 

In May 2020, the Company entered into a lease agreement amendment related to our headquarters in Woonsocket, Rhode Island. The agreement decreased the leased premises square footage and extended the current term, which was set to end in March 2021 prior to the amendment to June 2025. It additionally granted two 5-year term extension options. The Company was accounting for the lease in Woonsocket as a sale-leaseback with the building on the balance sheet as property and equipment, net and a corresponding financing obligation in long-term liabilities. Upon the execution of the lease amendment, the Company re-assessed the classification of the lease and determined it to be an operating lease, as the criteria for a sale had been met. As part of this re-classification, the Company derecognized the financing obligation of $2,390 from long-term liabilities and the amount related to the property and equipment, net of $2,357 from the balance sheet and recorded a ROU asset and lease liability of $1,457 respectively. The Company did not include either of the term extension options in the calculation of the ROU asset and lease liability.

 

In April 2020, the Company entered into a twelve-month sublease agreement for a portion of the distribution warehouse located in Riverside, California. Fixed sublease payments received are recognized on a straight-line basis over the sublease term in general and administrative expenses. In February 2021, the Company extended the existing sublease through September 2021.

In February 2021, Summer USA extended its lease at its Riverside, California distribution center. The existing lease was set to expire on September 30, 2021 and has been extended for 61 months through October 31, 2026. In addition, the amended lease grants a 60 month extension option. The company concluded that this is a modification to the existing lease and continues to be classified as operating. Upon the execution of the lease extension, the Company recorded an increase in ROU asset and lease liability of $13,583, respectively. The Company did not include the extension option in the calculation of the ROU asset and lease liability.

 

The Company identified and assessed the following significant assumptions in recognizing the right-of-use asset and corresponding liabilities:

 

 ·Expected lease term — The expected lease term includes both contractual lease periods and, when applicable, cancelable option periods when it is reasonably certain that the Company would exercise such options. TheseAs of April 3, 2021, these leases havehad remaining lease terms between 1.000.6 and 4.755.6 years. The Woonsocket lease has two 5-year extension options and the Canada lease has one 5-year extension option that havehas not been included in the lease term.

 

 ·Incremental borrowing rate — The Company’s lease agreements do not provide an implicit rate. As the Company does not have any external borrowings for comparable terms of its leases, the Company estimated the incremental borrowing rate based on secured borrowings available to the Company for the next 5 years. This is the rate the Company would have to pay if borrowing on a collateralized basis over a similar term in an amount equal to the lease payments in a similar economic environment.

 


 ·Lease and non-lease components — In certain cases the Company is required to pay for certain additional charges for operating costs, including insurance, maintenance, taxes, and other costs incurred, which are billed based on both usage and as a percentage of the Company’s share of total square footage. The Company determined that these costs are non-lease components and they are not included in the calculation of the lease liabilities because they are variable. Payments for these variable, non-lease components are considered variable lease costs and are recognized in the period in which the costs are incurred.

 

The components of the Company’s lease expense for the ninethree months ended September 26,April 3, 2021 and March 28, 2020 and September 28, 2019 were as follows:

 

 Nine Months Ended Nine Months Ended  

For the

three months ended

 
 September 26, 2020 September 28, 2019  April 3, 2021  

March 28, 2020

 
Operating lease cost $1,999  $1,867  $782  $621 
Variable lease cost $785  $890   56   267 
Less: sublease income  (500)     (250)   
Total lease expense $2,284  $2,757 
        
Weighted-average remaining lease term  1.0 year     
Weighted-average discount rate:  5.00%    
Total lease cost $588  $888 

 

Weighted-average remaining lease term5.3 years
Weighted Average discount rate:3.4%

 

Cash paid for amounts included in the measurement of the Company’s lease liabilities were $2,145$765 and $1,946$662 for the ninethree months ended September 26,April 3, 2021 and March 28, 2020 and September 28, 2019 respectively.

 

As of September 26, 2020,April 3, 2021, the present value of maturities of the Company’s operating lease liabilities were as follows:

 

Fiscal Year Ending:      
2020  757 
2021  2,448  $2,185 
2022  618   3,481 
2023  465   3,405 
2024  325   3,347 
2025  3,284 
Thereafter  164   2,672 
Less imputed interest  (271)  (1,624)
Total $4,506  $16,750 

 

The future fixed sublease receipts under non-cancelable operating leasesublease agreements as of September 26, 2020April 3, 2021 are as follows:

 

Fiscal Year Ending:      
2020  250 
2021  250   500 
Thereafter   
Total $500  $500 

 


Litigation

 

The Company is a party to various routine claims, litigation and administrative complaints incidental to its business, including claims involving product liability, employee matters and other general liability claims, most of which are covered by insurance. We are not aware of any such proceedings or claims that we believe will have, individually or in the aggregate, a material adverse effect on our business, results of operations or financial condition.

 

7.6.SHARE BASED COMPENSATION

 

The Company is currently authorized to issue up to 188,889 shares for equity awards under the Company’s 2012 Incentive Compensation Plan (as amended, “2012 Plan”). Periodically, the Company may also grant equity awards outside of its 2012 Plan as inducement grants for new hires. The Company was authorized to issue up to 333,334 shares for equity awards under its 2006 Performance Equity Plan (“2006 Plan”). In March 2017, the 2006 Plan expired and no additional equity awards can be granted under the 2006 Plan.

 

Under the 2012 Plan, awards may be granted to participants in the form of non-qualified stock options, incentive stock options, restricted stock, deferred stock, restricted stock units and other stock-based awards. Subject to the provisions of the plans, awards may be granted to employees, officers, directors, advisors and consultants who are deemed to have rendered or are able to render significant services to the Company or its subsidiaries and who are deemed to have contributed or to have the potential to contribute to the Company’s success. The Company accounts for options under the fair value recognition standard. Share-based compensation expense, net of forfeitures, for the ninethree months ended September 26,April 3, 2021 and March 28, 2020 was a credit of $7 and September 28, 2019 was $136 and $224,a credit of $11, respectively. Share based compensation expense is included in general and administrative expenses.

 


The fair value of each option award is estimated on the date of grant using the Black-Scholes option valuation model that uses the assumptions noted in the table below. The Company uses the simplified method to estimate the expected term of the options, but used an estimate for grants of “plain vanilla” stock options based on a formula prescribed by the Securities and Exchange Commission. Forfeitures are estimated at the time of grant and revised, if necessary, in subsequent periods if actual forfeitures differ from those estimates. Share-based compensation expense recognized in the condensed consolidated financial statements is based on awards that are ultimately expected to vest.

 

As of September 26, 2020,April 3, 2021, there were 65,17090,267 stock options outstanding and 17,68011,156 unvested restricted shares outstanding.

 

During the ninethree months ended September 26, 2020,April 3, 2021, the Company granted 21,43342,000 stock options and 25,202did not grant any shares of restricted stock, respectively.stock. The following table summarizes the weighted average assumptions used for stock options granted during the ninethree months ended September 26, 2020 and September 28, 2019.April 3, 2021.

 

  For the Nine
Months Ended
September 26,
2020
  For the Nine
Months Ended
September 28, 
2019
 
Expected life (in years)  4.7   5.0 
Risk-free interest rate  0.3%  2.3%
Volatility  98.9%  64.2%
Dividend yield  0%  0%
Forfeiture rate  26.5%  24.2%
For the Three
Months Ended
April 3, 2021
Expected life (in years)4.60
Risk-free interest rate0.7%
Volatility104.3%
Dividend yield0%
Forfeiture rate28.1%

 

As of September 26, 2020,April 3, 2021, there were 58,85132,214 shares available to grant under the 2012 Plan.

 


8.7.WEIGHTED AVERAGE COMMON SHARES

 

Basic and diluted earnings or loss per share (“EPS”) is based upon the weighted average number of common shares outstanding during the period. Diluted weighted average number of common shares outstanding also included common stock equivalents such as stock options and restricted shares. The Company does not include the anti-dilutive effect of common stock equivalents in the calculation of dilutive common shares outstanding.

 

A reconciliation of basic and diluted net income (loss) attributable to common stockholders is as follows:

 

Calculation of Basic and Diluted EPS For the Three
Months Ended
September 26, 2020
  For the Three
Months Ended
September 28, 2019
 
Weighted-average common shares outstanding - basic  2,126,497   2,104,207 
Dilutive effect of restricted shares  8,672    
Dilutive effect of stock options  20,622    
Weighted-average common shares outstanding – diluted  2,155,791   2,104,207 
Earnings (loss) per share - basic $1.04  $(0.79)
Earnings (loss) per share - diluted $1.03  $(0.79)

Calculation of Basic and Diluted EPS For the Nine
Months Ended
September 26, 2020
  For the Nine
Months Ended
September 28, 2019
  For the Three
Months Ended
April 3, 2021
  For the Three
Months Ended
March 28, 2020
 
Weighted-average common shares outstanding - basic  2,115,694   2,098,886 
Weighted-average common shares outstanding – basic  2,133,061   2,109,264 
Dilutive effect of restricted shares  1,956      8,306    
Dilutive effect of stock options  2,394      20,422    
Weighted-average common shares outstanding – diluted  2,120,044   2,098,886   2,161,789   2,109,264 
Earnings (loss) per share - basic $1.08  $(1.56)
Earnings (loss) per share - diluted $1.08  $(1.56)
Earnings (loss) per share – basic $0.12  $(0.57)
Earnings (loss) per share – diluted $0.12  $(0.57)

 

The computation of diluted common shares for the three and nine months ended September 26, 2020April 3, 2021 excluded 44,548 and 62,776 of69,845 stock options outstanding, respectively and excluded 9,008 and 15,7242,850 shares of restricted stock outstanding, respectively.outstanding. The computation of diluted common shares for the three and nine months ended SeptemberMarch 28, 20192020 excluded 112,29265,619 stock options and 31,14213,669 shares of restricted stock outstanding.

 


9.8.SUBSEQUENT EVENTS

 

The Company has evaluated subsequent events through the filing date of this Quarterly Report on Form 10-Q and determined that no subsequent events occurred that would require recognition in the condensed consolidated financial statements or disclosure in the notes thereto except as follows.

On October 15, 2020, the Company and its subsidiary, Summer Infant (USA), Inc., as borrowers, entered intoother than described in Note 3 related to a Third Amended and Restated Loan and Security Agreement (the “Third Restated BofA Agreement”)letter agreement with Bank of America, N.A., as agent, the financial institutions party to the agreement from time to time as lenders, and certain subsidiaries of the Company as guarantors. The Third Restated BofA Agreement provides for (i) a $40 million asset-based revolving credit facility, with a $5 million letter of credit sub-line facility, (ii) a $7.5 million term loan and (iii) a $2.5 million FILO (first-in, last-out) loan as described below. Proceeds from the Third Restated BofA Agreement were used to repay the Company’s outstanding term loan with Pathlight Capital, other related obligations, and to pay fees and transaction expenses associated with the closing of the Third Restated BofA Agreement, and may be used for paying obligations under the Third Restated BofA Agreement and for lawful corporate purposes, including working capital.

·Revolving Credit Facility - Total borrowing capacity under the revolving credit facility is based on a borrowing base, which is generally defined as 85% of eligible receivables plus the lesser of (i) 70% of the value of eligible inventory (subject to certain limitations) or (ii) 85% of the net orderly liquidation value (NOLV) of eligible inventory, less applicable reserves. The scheduled maturity date of loans under the revolving credit facility is October 15, 2025 (subject to customary early termination provisions). Loans under the revolving credit facility bear interest, at the Company’s option, at a base rate or at LIBOR, plus applicable margins based on average quarterly availability. Interest payments are due monthly, payable in arrears. The Company is also required to pay an annual non-use fee on unused amounts under the revolving credit facility, as well as other customary fees as are set forth in the Third Restated BofA Agreement. As of October 15, 2020, the applicable margin for base rate loans under the revolving credit facility was 1.25% and for LIBOR rate loans was 2.25%.

·Term Loan -The principal of the term loan will be repaid, on a quarterly basis, in installments of $375, with the first installment to be paid on January 1, 2021, until paid in full on termination and subject to mandatory repayment in certain circumstances. The scheduled maturity date of the term loan is October 15, 2025 or, if earlier, the date the revolving credit facility is terminated. The term loan bears interest, at the Company’s option, at a base rate or at LIBOR, plus applicable margins, and interest payments are due monthly, in arrears. As of October 15, 2020, the applicable margin for term loans at base rate was 2.50% and for term loans at LIBOR rate was 3.50%.

·FILO Loan - The total borrowing capacity under the FILO loan is the lesser of (i) the then applicable aggregate FILO commitment amount and (ii) a borrowing base, generally defined as a specific percentage of the value of eligible accounts, plus a specified percentage of the value of eligible inventory. The aggregate FILO commitment amount as of October 15, 2020 was $2.5 million, and such amount will be proportionately reduced on the first calendar day of each quarter beginning January 1, 2021 until the FILO loan is terminated at maturity on October 15, 2024. There can be no voluntary repayment on the FILO loan as long as there are loans outstanding under the revolving credit facility, unless (i) there is an overadvance under the FILO loan, or (ii) such prepayment is accompanied by a permanent dollar for dollar reduction in the aggregate FILO commitment amount such that, after giving effect to such prepayment and reduction, the outstanding principal amount of the FILO loan is equal to but does not exceed the lesser of (A) the aggregate FILO commitment amount and (B) the FILO borrowing base. The FILO loan bears interest, at the Company’s option, at a base rate or at LIBOR, plus applicable margins, and interest payments are due monthly, in arrears. As of October 15, 2020, the applicable margin for the FILO loan at base rate was 2.25% and for the FILO loan at LIBOR rate was 3.25%.

All obligations under the Third Restated BofA Agreement are secured by substantially all the assets of the Company. Summer Infant Canada Limited and Summer Infant Europe Limited, subsidiaries of the Company, are guarantors under the Third Restated BofA Agreement. The Third Restated BofA Agreement contains customary affirmative and negative covenants. Among other restrictions, the Company is restricted in its ability to incur additional debt, make acquisitions or investments, dispose of assets, or make distributions unless in each case certain conditions are satisfied. Until the term loan and FILO loan have been repaid in full, the Company must maintain a fixed charge coverage ratio at the end of each fiscal month of at least 1.00 to 1.00 for the twelve-month period then ended. After the term loan and FILO loan have been repaid in full, the Company will be required to maintain the fixed charge coverage ratio if availability falls below $5.0 million.

The Third Restated BofA Agreement also contains customary events of default, including if the Company fails to comply with any required financial covenants, if there is an event of default under the PPP Loan and the occurrence of a change of control. In the event of a default, all of the obligations of the Company and its subsidiaries under the Third Restated BofA Agreement may be declared immediately due and payable. For certain events of default relating to insolvency and receivership, all outstanding obligations become due and payable.BofA.

 


ITEM 2.Management’s Discussion and Analysis of Financial Condition and Results of Operations

 

The statements contained in this Quarterly Report on Form 10-Q that are not purely historical are forward-looking information and statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. All forward-looking statements included in this document are based on information available to us on the date hereof. It is important to note that our actual results could differ materially from those projected in such forward-looking statements contained in this Quarterly Report on Form 10-Q. These forward-looking statements include statements concerning our expectations regarding the impact of the COVID-19 resurgence, softening consumer demand and supply chain challengespandemic on our financial condition and results of operations in the fourthsecond quarter of 2021 and long term; anticipated savings from our ongoing restructuring efforts; expected savings on interest cost as a result of our restated loan agreement with Bank of America; the impact of existing tariffs on the cost of certain of our imported products and the expected effect of our mitigation efforts;longer term and our expected cash flow and liquidity for the next 12 months. These statements are based on current expectations that involve numerous risks and uncertainties.  These risks and uncertainties include the continuing impact and widespread nature of the COVID-19 outbreakpandemic on our business operations, and the U.S. and global economies; changesthe ongoing disruption in international trade policyglobal supply chains and increased costs of shipping and transporting our products from manufacturers to the impositionCompany, and from the Company to our customers; the impact of existing tariffs and any increased or additional tariffs, or other fees byimport or export taxes, on the United States or other countries oncost of our products;products, and therefore demand for our products, the concentration of our business with retail customers; potential liquidity problems or bankruptcy of our customers and their ability to pay us in a timely manner; our ability to comply with financial and other covenants in our debt agreement; whether we will be ableagreements; our ability to obtain forgiveness for all or part ofwork with our PPP loan;lenders to amend our existing debt agreements, if required; our ability to introduce new products or improve existing products that satisfy consumer preferences; our ability to develop new or improved products in a timely and cost-efficient manner; our ability to compete with larger and more financially stable companies in our markets; our dependence on key personnel; our reliance on foreign suppliers and potential disruption in foreign markets in which we operate; potential increases in the cost of raw materials used to manufacture our products; our ability to obtain forgiveness of our outstanding PPP Loan; compliance with safety and testing regulations for our products; potential product liability claims arising from use of our products; unanticipated tax liabilities; a potential impairment of other intangible assets; and other risks as detailed in our Annual Report on Form 10-K for the year ended December 28, 2019, as amended, our Quarterly Reports on Form 10-Q for the quarters ended March 28, 2020 and June 27, 2020, and subsequent filings with the Securities and Exchange Commission.January 2, 2021. All these matters are difficult or impossible to predict accurately, many of which may be beyond our control. Although we believe that the assumptions underlying our forward-looking statements are reasonable, any of the assumptions could be inaccurate and, therefore, there can be no assurance that the forward-looking statements included in this Quarterly Report on Form 10-Q will prove to be accurate.

 

The following discussion is intended to assist in the assessment of significant changes and trends related to the results of operations and financial condition of our Company and our consolidated subsidiaries.  This Management’s Discussion and Analysis should be read together with the unaudited interim condensed consolidated financial statements and related notes included elsewhere in this filing and with our consolidated financial statements for the year ended December 28, 2019January 2, 2021 included in our Annual Report on Form 10-K for the year ended December 28, 2019, as amended (“2019(the “2020 Form 10-K”).

 

Note that all dollar amounts in this section are in thousands of U.S. dollars, except share and per share data.

 

Overview

 

We are an infant and juvenile products company originally founded in 1985 and have publicly traded on the Nasdaq Stock Market since 2007doing business under the symbol “SUMR.”name SUMR Brands. We are a recognized authority in the infant and juvenile product industry, providing parents and caregivers a full range of innovative, high-quality, and high-value products to care for babies and toddlers. We seek to improve the quality of life of parents, caregivers, and babies through our product offerings.offerings, while at the same time maximizing shareholder value over the long term.

 

We operate in one principal industry segment across geographically diverse marketplaces, selling our products primarily in North Americaglobally to large, national retailers as well as independent retailers, and on our partner’s websites, and our own direct-to-consumer websites.direct to consumer website. In North America, our customers include Amazon.com, Wal-Mart, Target, Buy Buy Baby, Home Depot, and Lowe’s. Our largest European-based customers are Smyths Toys and Amazon. We also sell through international distributors, representatives, and to select international retail customers in geographic locations where we do not have a direct sales presence.

 

In the thirdfirst quarter of 2020,2021, sales declined 2.0%10.3% as compared to the prior year period, principallyprimarily due to supply chain and logistical issues that resulted in missed shipment opportunities as customer demand was strong in the quarter. Additionally, international sales declined compared to the first quarter of 2020 as a result of higher closeout sales due to the restructuringliquidation of our international business ininventory associated with the second quarter, transitioning more of our business to direct import, the negative effectclosure of the COVID-19 pandemic on our supply chain, and reduced demandUK warehouse. Gross margin declined to 29.4% from mid-tier brick-and-mortar stores. Gross profit increased on lower sales, and gross margin improved31.0% primarily due primarily to a favorableshift in customer mix and an increase in certain raw material costs, primarily resin, as well as an increase in freight costs. The first quarter of higher product margin categories and lower closeout sales as compared to last year’s quarter.2020 also included approximately a $500 benefit from the temporary tariff exclusion on certain items, primarily gates which expired in August 2020. General and administrative expenses declined 17.5%13.7% as compared to the prior period as the Company benefitedcontinued to benefit from theits restructuring actions takeninitiatives implemented in the first and second quartersquarter of 2020. Net income per diluted share for the quarter was $1.03$0.12 per share as compared to a net loss of $0.57 per diluted share of $0.79 infor the comparable prior period. Net income for the quarter reflected a tax benefit that resulted from a modification of interest expense deductibility under the U.S. CARES Act.

 


In early 2020 and prior to

Impact of the COVID-19 outbreak in the U.S., we announced restructuring initiatives to further streamline operations and improve our financial outlook. We anticipated that these actions would result in annualized cost savings of approximately $7,500. As of the end of September 2020, we had taken most of these actions, including headcount reductions, reductions in facility space, and other cost reductions, and believe we are on track to realize the expected $7,500 in annualized cost savings.

As discussed below, in the third quarter we applied for and received a loan under the Paycheck Protection Program (“PPP”) under the U.S. CARES Act, and, additionally, following the end of the third quarter, we successfully refinanced our existing debt which we expect to lower our interest cost by approximately $2.0 million annually based on current borrowing levels and to provide for our working capital needs as we navigate the uncertainty of COVID-19.

Outlook.Pandemic The COVID-19 pandemic continued to impact our business in the third quarter, as we experienced challenges in our shipping and distribution channels throughout our global supply chain and continued to see lower demand from our mid-sized and smaller customers, and softening consumer demand.

Because our products are considered “essential,” we have continued to ship products throughout the pandemic and have been able to maintain operations at our main distribution center.. As discussed in prior filings, early in the pandemicour 2020 Form 10-K, we experienced some delays in manufacturing and shipment of our products to the U.S., throughout 2020, as the majority of our products are sourced from China with the rest sourced in North America. We continue to see disruption in our shipping and distribution channels throughout our global supply chain including congestion in ports and distribution centers, container shortages and lack of truck drivers. The potential exists that we might not be able to meet demand due to these challenges and for certain products that are manufactured by suppliers in China or elsewhere that may be subject to closure due to the resurgence of COVID-19 outbreaks.China.

 

In March 2020, we began to see customers that have retail stores reduce orders as they experienced or anticipated closures of those stores. While we did see an uptick in sales to those customers with significant e-commerce capabilities, it did not offset the reduced orders from our mid-size and smaller customers who remained closedwhich continued throughout 2020.

During the latter half of 2020, manufacturing and shipments from China returned to more normal levels, however suppliers that were located in other areas, including Mexico, were subject to closure as a result of the COVID-19 pandemic. In the first quarter of 2021, we started to experience additional supply chain disruption in terms of logistics, issues securing necessary containers and transportation, as well as on-going manufacturing challenges in North America due to the impact of COVID-19 on our North American suppliers. As a result, in the early partfirst quarter, we were unable to meet demand for certain products that were manufactured by suppliers subject to COVID related issues such as an inability to secure necessary labor for manufacturing. The Company is working on various alternatives, including but not limited to, actively working with multiple transportation companies to secure better supply.

We expect that our sales in the second quarter of 2021 will continue to be impacted by the third quarter.COVID-19 pandemic due to continued supply chain issues and isolated shutdowns of brick-and-mortar stores in certain geographies. We believe that customers with e-commerce capabilities will continue to have increasedhigh demand butand we hope that stores will continue to reopen across the current softening in consumer demand could temper anyU.S. and we will see a corresponding increase in orders from customers.customers with brick and mortar retail stores. However, given the unpredictability of the COVID-19 pandemic, it is possible that some stores will remain closed, dueor that outbreaks may reoccur later in the year. With our mid-size and smaller customers, we continue to experience some of these customers asking for extensions in payment terms. We expect these customers may experience financial difficulties, and we are taking steps to limit risk of non-payment from these customers. Additionally, the Company anticipates transportation cost increases and also anticipates cost increases related to the resurgencepurchase of COVID-19 outbreaks or that these customers will close or reduce the numberproducts from its suppliers as a consequence of stores that they operate in responseraw material market price increases including, but not limited to, the COVID-19 pandemic. . 

We continue to assess the impact of the COVID-19 pandemic on its supply chain, consumer demandresin, metal, and overall business operations through the remainder of 2020 and into 2021, and duewood. Due to these issues currently expect revenue and earnings incost increases, the fourth quarterCompany is instituting price increases with customers to mitigate some of 2020 will be reduced compared to the third quarter. Additionally, we believe the recent COVID-19 resurgence in the United States and in other countries has added greater uncertainty and unpredictable economic consequences in the coming months, and therefore we cannot currently predict how it will impact our business in the long term.these costs.

 

Summary of Critical Accounting Policies and Estimates

 

There have been no significant changes in our critical accounting policies and estimates during the ninethree months ended September 26, 2020April 3, 2021 from our critical accounting policies and estimates disclosed under “Management’s Discussion and Analysis of Financial Condition and Results of Operations” in our 20192020 Form 10-K.

 

Results of Operations

 

 For the Three Months Ended 
 For the three months ended
(Unaudited)
  For the nine months ended
(Unaudited)
  (Unaudited) 
 September
 26, 2020
  September 
28, 2019
  September 
26, 2020
  September 
28, 2019
  April 3, 2021 March 28, 2020 
Net sales $40,704  $41,523  $119,256  $130,486  $36,201  $40,338 
Cost of goods sold  27,168   28,928   79,178   89,599   25,544   27,835 
Gross profit  13,536   12,595   40,078   40,887   10,657   12,503 
General & administrative expenses  6,890   8,353   21,766   26,255 
Selling expenses  2,802   3,597   9,984   10,981 
General and administrative expense  7,027   8,147 
Selling expense  2,407   3,444 
Depreciation and amortization  783   919   2,563   2,808   560   967 
Operating income (loss)  3,061   (274)  5,765   843   663   (55)
Interest expense, net  1,017   1,191   3,548   3,733   336   1,410 
Income (loss) before provision for income taxes  2,044   (1,465)  2,217   (2,890)
(Benefit) provision for income taxes  (166)  195   (70)  392 
Income (loss) before income taxes  327   (1,465)
Provision (benefit) for income taxes  67   (255)
Net income (loss) $2,210  $(1,660) $2,287  $(3,282) $260  $(1,210)

 


Three Months ended September 26, 2020April 3, 2021 compared with Three Months ended SeptemberMarch 28, 20192020

 

Net sales decreased 2.0%10.3% from $41,523$40,338 for the three months ended SeptemberMarch 28, 20192020 to $40,704$36,201 for the three months ended September 26, 2020April 3, 2021. The decrease was primarily as a result of the strategic restructuring of our international business that resultedinability to ship retail orders in a decline of international sales, transitioning more of our businessfull due to direct import,COVID-19 related manufacturing and the negative effectlogistical issues, including securing containers, as effects of the COVID-19 pandemic on ourcontinued to disrupt the global supply chain and on demand from mid-tier brick-and-mortar stores just starting to reopen. Sales to our top customers, especially through their ecommerce channels, remained strong, and we increased sales in our gates, potty, bath, entertainers, and playard categories.chain.

 

Cost of goods sold includes cost of the finished product from suppliers, tariffs/duties on certain imported items, freight-in from suppliers, and miscellaneous charges. The components of cost of goods sold remained substantially the same for the quarter ended September 26, 2020April 3, 2021 as compared to the quarter ended SeptemberMarch 28, 2019.2020.

 

Gross profit increased 7.5%decreased 14.8% from $12,595$12,503 for the three months ended SeptemberMarch 28, 20192020 to $13,536$10,657 for the three months ended September 26, 2020.April 3, 2021. Gross profitmargin as a percent of net sales increaseddeclined from 30.3%31.0% for the three months ended SeptemberMarch 28, 20192020 to 33.3%29.4% for the three months ended September 26, 2020.April 3, 2021. Gross profit and gross profitdeclined as a percentresult of netlower sales increased due to improved marginsin 2021 as well as a shift in customer mix and an increase in certain raw material costs, primarily resin as well as an increase in freight costs. The first quarter of 2020 also included a benefit from the temporary tariff exclusion on certain items, primarily gates bath, specialty blankets, strollers, and entertainers due to lower tariffs and fewer closeout sales at low margins in the three months ended September 26, 2020 compared to the three months ended September 28, 2019. Tariff exclusions received since December 2019which expired in August 2020, however, we have been taking actions that we expect to mitigate the resumption of these tariffs with customer price increases, supplier concessions, and cost reductions.2020.

 

General and administrative expenses decreased 17.5%13.7% from $8,353$8,147 for the three months ended SeptemberMarch 28, 20192020 to $6,890$7,027 for the three months ended September 26, 2020.April 3, 2021. General and administrative expenses decreaseddeclined from 20.1% of net sales for `the three months ended September 28, 2019 to 16.9%20.2% of net sales for the three months ended September 26, 2020.March 28, 2020 to 19.4% of net sales for the three months ended April 3, 2021. The decline in dollars and as a percent of sales was primarily due to the Company’sCompany realizing the full impact of its restructuring activities initiatedinitiatives that were implemented at varying dates in the first quarter of 2020 that included a reduction in work force and other cost reductions.2020.

 

Selling expenses decreased 22.1%30.1% from $3,597$3,444 for the three months ended SeptemberMarch 28, 20192020 to $2,802$2,407 for the three months ended September 26, 2020.April 3, 2021. Selling expenses also decreased as a percent of net sales from 8.7%8.5% for the three months ended SeptemberMarch 28, 20192020 to 6.9%6.6% for the three months ended September 26, 2020.April 3, 2021. The decrease in selling expense dollars and as a percent of net sales werewas primarily attributable to decreasedlower sales and a shift in customer mix resulting in a decrease in cooperative advertisements and freight out and consumer advertising costs for the three months ended September 26, 2020this year as compared to the three months ended SeptemberMarch 28, 2019.2020.

 

Depreciation and amortization decreased 14.8%declined 42.1% from $919$967 for the three months ended SeptemberMarch 28, 20192020 to $783$560 for the three months ended September 26, 2020. The decreaseApril 3, 2021. Depreciation in the three months ended March 28, 2020 included $125 of accelerated depreciation and amortization was attributable to lower capital investment over the past year.on certain disposed assets.

 

Interest expense decreased 14.6%declined 76.2% from $1,191$1,410 for the three months ended SeptemberMarch 28, 20192020 to $1,017$336 for the three months ended September 26, 2020.April 3, 2021. Interest expense decreased due toprimarily as a result of a lower interest rate associated with the completion of a debt levels.refinancing with Bank of America in the fourth quarter of 2020, but also as a result of lower total debt.

 

For the three months ended SeptemberMarch 28 2019,2020, we recorded a $195 provision$255 tax benefit for income taxes on $1,465 of pretax loss, reflecting an estimated 17.4% tax rate for the quarter. For the three months ended April 3, 2021, we recorded a $67 tax provision for income taxes on $327 of pretax income, reflecting an estimated 20.7% tax rate for the quarter. The tax rate for the three months ended March 28, 2020 included a $311$262 discrete valuation allowance charge for nondeductible interest expense. For the three months ended September 26, 2020, we recorded a $166 benefit for income taxes on $2,044 of pretax income. The benefit for income tax rate for the three months ended September 26, 2020 included a $362 discrete reductionApril 3, 2021 includes an expected decrease in valuation allowance chargeof $262 for the utilization of nondeductible interest expense attributable to revised final regulations released in July 2020 as part of the U.S. CARES Act.

Nine Months ended September 26, 2020 compared with Nine Months ended September 28, 2019

Net sales decreased 8.6% from $130,486 for the nine months ended September 28, 2019 to $119,256 for the nine months ended September 26, 2020 primarily as a result of the strategic restructuring of our international business that resulted in a decline of international sales, transitioning more of our business to direct import, and the negative effect of the COVID-19 pandemic on our supply chain and on demand from our customers and consumers with many mid-tier brick-and-mortar stores being closed earlier in the year. Sales to our top customers, especially through their ecommerce channels, remained strong and we increased sales in our potty and playard categories.prior years.

 


Cost of goods sold includes cost of the finished product from suppliers, tariffs/duties on certain imported items, freight-in from suppliers, and miscellaneous charges. The components of cost of goods sold remained substantially the same for the nine months ended September 26, 2020 as compared to the nine months ended September 28, 2019.

Gross profit decreased 2.0% from $40,887 for the nine months ended September 28, 2019 to $40,078 for the nine months ended September 26, 2020. Gross profit as a percent of net sales increased from 31.3% for the nine months ended September 28, 2019 to 33.6% for the nine months ended September 26, 2020. Gross profit dollars decreased primarily due to lower sales. Gross profit as a percent of net sales improved primarily due to tariff exclusions on certain gate, bath, and bedrail products that became effective between December 2019 and May 2020 and were retroactive to September 2018 resulting in $2,370 of the tariff refunds as a benefit to cost of sales in the nine months ending September 26, 2020. Tariff exclusions received since December 2019 expired in August 2020, however, we have been taking actions that we expect to mitigate the resumption of these tariffs with customer price increases, supplier concessions, and cost reductions.

General and administrative expenses decreased 17.1% from $26,255 for the nine months ended September 28, 2019 to $21,766 for the nine months ended September 26, 2020. General and administrative expenses decreased from 20.1% of net sales for the nine months ended September 28, 2019 to 18.3% of net sales for the nine months ended September 26, 2020. The decline in dollars and as a percent of sales was primarily due to the Company’s restructuring initiated in the first quarter of 2020 that included a reduction in work force and other cost reductions partially offset by severance and other restructuring costs.

Selling expenses decreased 9.1% from $10,981 for the nine months ended September 28, 2019 to $9,984 for the nine months ended September 26, 2020. Selling expenses as a percent of net sales was 8.4% for the nine months ended September 28, 2019 and for the nine months ended September 26, 2020. The decrease in selling expense dollars is primarily attributable to lower selling costs such as cooperative advertising and freight on lower sales.

Depreciation and amortization decreased 8.7% from $2,808 for the nine months ended September 28, 2019 to $2,563 for the nine months ended September 26, 2020. The decrease in depreciation was attributable to the decline in capital investment primarily over the past year.

Interest expense decreased 5.0% from $3,733 for the nine months ended September 28, 2019 to $3,548 for the nine months ended September 26, 2020. The decrease in interest expense was primarily attributable to lower debt levels partly offset by the write off of $266 of previously unamortized prepaid finance fees associated with the reduction in the total revolver commitments under the Company’s Bank of America credit facility in March 2020.

For the nine months ended September 28, 2019, we recorded a $392 provision for income taxes on $2,890 of pretax loss. The provision for income taxes for the nine months ended September 28, 2019, included a $805 discrete valuation allowance charge for nondeductible interest expense. For the nine months ended September 26, 2020, we recorded a $70 benefit provision for income taxes on $2,217 of pretax income. The benefit for income taxes for the nine months ended September 26, 2020, included a $624 discrete reduction in valuation allowance charge for nondeductible interest expense attributable to revised final regulations released in July 2020 as part of the U.S. CARES Act.

Liquidity and Capital Resources

 

We fund our operations and working capital needs through cash generated from operations and borrowings under our credit facilities.facility.

 

In our typical operational cash flow cycle, inventory is purchased in U.S. dollars to meet expected demand plus a safety stock. The majority of our suppliers are based in Asia and such inventory typically takes from three to four weeks to arrive at the various distribution points we maintain in the United States and Canada. Payment terms for these vendors are approximately 60-75 days from the date the product ships from Asia and therefore we are generally paying for the product a short time after it is physically received in the United States. In turn, sales to customers generally have payment terms of 60 days, resulting in an accounts receivable and increasing the amount of cash required to fund working capital. To bridge the gap between paying our suppliers and receiving payment from our customers for goods sold, we rely on our credit facilities.facility.

 

The majority of our capital expenditures are for tools and molds related primarily to new product introductions. We receive indications from retailers near the middle of each year as to what products they will be taking into their product lines for the upcoming year. Based on these indications, we will then acquire the tools and molds required to build and produce the products. In most cases, the payments for the tools are spread out over a three to four month period.

 


For the ninethree months ended September 26, 2020,April 3, 2021, net cash provided by operating activities totaled $14,797 primarily due to increased profitability and improved working capital efficiency. For the nine months ended September 28, 2019, net cash provided by operating activities totaled $1,142$1,321 primarily due to a reduction in accounts receivable and inventory, during the yearmostly offset bywith a decreasereduction in accounts payable and accrued expenses.an increase in accounts receivable. While part of the decline in inventory was a result of a planned reduction from an elevated balance at year-end, the decline was exacerbated by supply chain issues. We anticipate continued supply chain issues in the second quarter and likely beyond. Net cash provided by operating activities for the three months ended March 28, 2020 was $5,069 primarily due to a reduction in inventory and accounts receivable.

 

For the ninethree months ended September 267,April 3, 2021, net cash used in investing activities was approximately $191. For the three months ended March 28, 2020, net cash used in investing activities was approximately $1,135. For the nine months ended September 28, 2019, net cash used in investing activities was approximately $1,913.$245.

 

Net cash used in financing activities was approximately $13,290$1,184 for the ninethree months ended September 26, 2020. Cash provided by operating activities were primarily used to reduce our bank borrowingsApril 3, 2021 which is comprised of $375 and $156 required payments on our credit facilities.the term and FILO facilities, respectively, as well as a paydown of the ABL facility as a consequence of generating cash flow from operations. Net cash provided byused in financing activities was approximately $828$4,705 for the ninethree months ended SeptemberMarch 28, 20192020 driven principally by reductions in inventory and reflected borrowings on our credit facilities primarily to reduce supplier payables. In October 2020, we refinanced our existing debt which we expect to lower our interest cost by approximately $2.0 million annually based on current borrowing levels.accounts receivable.

 

Primarily as a result of the above factors, net cash increaseddecreased for the ninethree months ended September 26, 2020April 3, 2021 by $476,$63, resulting in a cash balance of approximately $871$447 at September 26, 2020.April 3, 2021.

Capital Resources

 

In addition to operating cash flow, we also rely on our asset-based revolving credit facility and FILO loan with Bank of America, N.A. to meet our financing requirements, which isare subject to changes in our inventory and account receivable levels. We also received a PPP loan in August 2020, the proceeds of which we are usingregularly evaluate market conditions, our liquidity profile, and various financing alternatives for opportunities to pay for certain qualifying expenses, including payroll costs, rent and utility costs.enhance our capital structure.

 

However, ifIf we are unable to meet our current financial forecast, experience a more severe impact from the COVID-19 pandemic on our business than expected,projections, do not adequately control expenses, are unable to mitigate the impact of tariffs, or adjust our operations accordingly, we may experience constraints on our liquidity and may not meet the financial and other covenants under our revolving credit facility, thatterm loan and FILO loan, which could impact our borrowing availability. There is no assurance that we will meet all of our financial or other covenants in the future, or that our lender will grant waivers or agree to amend the terms of our loan agreement if there are covenant violations. In such case, we may be required to seek to raise additional funds through debt or equity financings, restructure our existing debt, engage in strategic collaborations, and/or a strategic transaction that is in the best interest of our stockholders. Any such financing or strategic transaction could result in significant dilution to our existing stockholders, depending on the terms of the transaction. If we are unable to identify a strategic transaction, raise additional funds, and/or restructure our existing debt, our operations could be limited and we may not be able to meet all of our obligations under our revolving credit facility, and term loan agreement.and FILO loan.

 


Based on past performance and current expectations, we believe that our anticipated cash flow from operations and availability under the Third Restated BofA Agreementour existing credit facility are sufficient to fund our working capital, capital expenditures and debt service requirements for at least the next 12 months.

 

Credit FacilityLoan Agreement with BofA

 

On October 15, 2020, weWe and our wholly owned subsidiary, Summer Infant (USA), Inc., as borrowers, entered intoare parties to a Third Amended and Restated Loan and Security Agreement (the “Third Restated BofA“Loan Agreement”) with Bank of America, N.A. (“BofA”), as agent, that replaced our existing agreement with BofA. The Third Restated BofA Agreement provides for (i) a $40 million$40,000 asset-based revolving credit facility, with a $5 million$5,000 unused letter of credit sub-line facility as of January 2, 2021, (ii) a $7.5 million$7,500 term loan and (iii) a $2.5 million$2,500 FILO (first-in, last-out) loan as described below. Proceeds from Third Restatedloan. The Loan Agreement replaced our prior credit facility with BofA Agreement were used to repay the Company’s outstandingand term loan with Pathlight Capital, other related obligations,Capital. As of April 3, 2021 the outstanding revolving credit facility, FILO and to pay fees and transaction expenses associated with the closing of the Third Restated BofA Agreement, and may be used for paying obligations under the Third Restated BofA Agreement and for lawful corporate purposes, including working capital. For information about our prior agreement with BofA and prior term loan agreement with Pathlight Capital that was repaid in connection with the Third Restated BofA Agreement, please see Note 3balances were $20,805, $2,188 and $6,750, respectively.

Pursuant to the unaudited financial statements included in this Quarterly Report on Form 10-Q.

Under the Third Restated BofALoan Agreement, total borrowing capacity under the revolving credit facility is based on a borrowing base, which is generally defined as 85% of eligible receivables plus the lesser of (i) 70% of the value of eligible inventory (subject to certain limitations) or (ii) 85% of the net orderly liquidation value (NOLV) of eligible inventory, less applicable reserves. The scheduled maturity date of the loans under the revolving credit facility is October 15, 2025 (subject to customary early termination provisions). Loans under the revolving credit facility bear interest, at our option, at a base rate or at LIBOR, plus applicable margins based on average quarterly availability. Interest payments are due monthly, payable in arrears. We are also required to pay an annual non-use fee on unused amounts under the revolving credit facility, as well as other customary fees as are set forth in the agreement.Loan Agreement. As of October 15, 2020,April 3, 2021, the applicable margin forinterest rate on LIBOR based revolver loans and on base rate loans under the revolving credit facility was 1.25% and for LIBOR raterevolver loans was 2.25%.2.625% and 4.500%, respectively.

 


The principal of the term loan under the Third Restated BofA Agreement willis to be repaid, on a quarterly basis, in installments of $375,000, with the first installment to be paid on January 1, 2021,$375, until paid in full on termination and subject to mandatory repayment in certain circumstances. The scheduled maturity date of the term loan is October 15, 2025 or if earlier, the dateif the revolving credit facility is terminated. The term loan bears interest, at our option, at a base rate or at LIBOR, plus applicable margins, and interest payments are due monthly, in arrears. As of October 15, 2020,January 2, 2021, the applicable margin forinterest rate on LIBOR based term loans atand on base rate was 2.50% and for term loans at LIBOR rate was 3.50%. 3.875% and 5.75%, respectively.

The total borrowing capacity under the FILO loan is the lesser of (i) the then applicable aggregate FILO commitment amount and (ii) a borrowing base, generally defined as a specific percentage of the value of eligible accounts, plus a specified percentage of the value of eligible inventory. The aggregate FILO commitment amount as of October 15, 2020 was $2.5 million, and such amount will be proportionately reduced each quarter until the FILO loan is terminated at maturity on October 15, 2024. There can be no voluntary repayment on the FILO loan as long as there are loans outstanding under the revolving credit facility, unless (i) there is an overadvance under the FILO loan, or (ii) such prepayment is accompanied by a permanent dollar for dollar reduction in the aggregate FILO commitment amount such that, after giving effect to such prepayment and reduction, the outstanding principal amount of the FILO loan is equal to but does not exceed the lesser of (A) the aggregate FILO commitment amount and (B) the FILO borrowing base. The FILO loan bears interest, at our option, at a base rate or at LIBOR, plus applicable margins, and interest payments are due monthly, in arrears. As of October 15, 2020,April 3, 2021, the applicable margin for theinterest rate on LIBOR based FILO loan atloans and on base rate FILO loans was 2.5%3.625% and for the FILO loan at LIBOR rate was 3.25%.5.50%, respectively.

 


All obligations under the Third Restated BofALoan Agreement are secured by substantially all the assets of the Company, and our assets. Our subsidiaries, Summer Infant Canada Limited and Summer Infant Europe Limited, are guarantors under the Third Restated BofALoan Agreement. The Third Restated BofALoan Agreement contains customary affirmative and negative covenants. Among other restrictions, we are restricted in our ability to incur additional debt, make acquisitions or investments, dispose of assets, or make distributions unless in each case certain conditions are satisfied. Until the term loan and FILO loan have been repaid in full, we must maintain a fixed charge coverage ratio at the end of each fiscal month of at least 1.00 to 1.00 for the twelve-month period then ended. After the term loan and FILO loan have been repaid in full, we will be required to maintain the fixed charge coverage ratio if availability falls below $5.0 million.$5,000.

 

The Third Restated BofALoan Agreement also contains customary events of default, including if we fail to comply with any required financial covenants, if there is an event of default under the PPP Loan (described below) and the occurrence of a change of control. In the event of a default, all of the obligations under the Third Restated BofALoan Agreement may be declared immediately due and payable. For certain events of default relating to insolvency and receivership, all outstanding obligations become due and payable.

 

For additional information on the Loan Agreement, please see Note 3 to our condensed consolidated financial statements included in this Quarterly Report.

PPP Loan

In 2020, we applied for and received loan proceeds of $1,956 (the “PPP Loan”) pursuant to the Paycheck Protection Program (“PPP”) administered by the U.S. Small Business Administration under the U.S. CARES Act. The PPP Loan, which was in the form of a promissory note, between the Company and BofA, as the lender, matures on July 27, 2025 and bears interest at a fixed rate of 1% per annum.  On February 18, 2021, the Company applied for full forgiveness of the PPP Loan through Bank of America. Bank of America has since reviewed the application and supporting documentation and they have forwarded the application to the Small Business Administration (“SBA”) for its review. For additional information on the PPP Loan, see Note 3 to our condensed consolidated financial statements included in this Quarterly Report.

ITEM 3.Quantitative and Qualitative Disclosures About Market Risk

 

As a smaller reporting company, as defined by Rule 12b-2 of the Exchange Act and in Item 10(f)(1) of Regulation S-K, we are electing scaled disclosure reporting obligations and therefore are not required to provide the information requested by this Item.

 

ITEM 4.Controls and Procedures

 

Evaluation of Disclosure Controls and Procedures

 

As required by Rule 13a-15(b) under the Securities Exchange Act of 1934, as of the end of the period covered by this Quarterly Report on Form 10-Q, we carried out an evaluation, under the supervision and with the participation of our Chief Executive Officer and our Interim Chief Financial Officer, of the effectiveness of our disclosure controls and procedures, as of September 26, 2020.April 3, 2021. Our Chief Executive Officer and Interim Chief Financial Officer have concluded, based on this evaluation, that our controls and procedures were effective as of September 26, 2020.April 3, 2021.

 

Changes in Internal Control Over Financial Reporting

 

There was no change in our internal control over financial reporting that occurred during the period covered by this Quarterly Report on Form 10-Q that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.

 


PART II.  OTHER INFORMATION

 

ITEM 1.Legal Proceedings

 

The Company is a party to various routine claims, litigation and administrative complaints incidental to its business, including claims involving product liability, employee matters and other general liability claims, most of which are covered by insurance. We are not aware of any such proceedings or claims that we believe will have, individually or in the aggregate, a material adverse effect on our business, results of operations or financial condition.

 

ITEM 1A.Risk Factors

 

There have been no material changes from the risk factors previously disclosed in Part I, Item 1A, “Risk Factors,” of our 20192020 Form 10-K and Part II, Item 1A, “Risk Factors,” of our Quarterly Report on Form 10-Q for the quarters ended March 28, 2020 and June 27, 2020.10-K.

 

ITEM 2.Unregistered Sales of Equity Securities and Use of Proceeds.

 

None.

 

ITEM 3.Defaults Upon Senior Securities

 

None.

 


ITEM 4.Mine Safety Disclosures

 

Not applicable.

 

ITEM 5.Other Information.

 

Not applicable.On April 16, 2021, the Company, Summer Infant (USA), Inc., as borrowers, and certain subsidiaries of the Company as guarantors, entered into a letter agreement with BofA with respect to the Loan Agreement pursuant to which the maximum percentage of accounts owing from Wal-Mart that may be included in eligible accounts under the Loan Agreement was increased from 35% to 45%, effective from March 31, 2021 through July 31, 2021. A copy of the letter agreement is filed herewith as Exhibit 10.1 and is incorporated herein by reference.

 

ITEM 6.Exhibits

 

The exhibits listed in the Exhibit Index immediately preceding the signature page hereto are filed as part of this Quarterly Report on Form 10-Q.

 


EXHIBIT INDEX

 

Exhibit No. Description
   
10.110.1+ Letter Agreement, dated as of July 14, 2020,April 16, 2021, among Bank of America, N.A., as ABL Agent and ABL Lender, Summer Infant, Inc. and Summer Infant (USA), Inc., as borrowers, the guarantors from time to time party thereto, and Pathlight Capital LLC, as agent for the Term Loan Lender (Incorporated by reference to Exhibit 10.4 to the Registrant’s Quarterly Report on Form 10-Q filed on August 11, 2020)
10.2Amendment No. 6 to Second Amended and Restated Loan and Security Agreement, dated as of August 10, 2020, among Summer Infant, Inc. and Summer Infant (USA), Inc., as borrowers, the guarantors from time to time party thereto, the financial institutions from time to time party thereto as lenders, and Bank of America, N.A., as agent for the lenders (Incorporated by reference to Exhibit 10.5 to the Registrant’s Quarterly Report on Form 10-Q filed on August 11, 2020)
10.3Amendment No. 5 to Term Loan and Security Agreement, dated as of August 10, 2020, among Summer Infant, Inc. and Summer Infant (USA) Inc., as borrowers, the guarantors from time to time party thereto, the financial institutions from time to time party thereto as lenders, and Pathlight Capital LLC, as agent for the lenders (Incorporated by reference to Exhibit 10.6 to the Registrant’s Quarterly Report on Form 10-Q filed on August 11, 2020)
10.4Letter Agreement dated May 12, 2020, among Edmund J. Schwartz, Summer Infant, Inc. and Summer Infant (USA), Inc. (Incorporated by reference to Exhibit 10.1 to the Registrant’s Current Report on Form 8-K filed on October 1, 2020)
10.5Amendment dated September 29, 2020 to Letter Agreement among Edmund J. Schwartz, Summer Infant, Inc. and Summer Infant (USA), Inc. dated May 12, 2020 (Incorporated by reference to Exhibit 10.2 to the Registrant’s Current Report on Form 8-K filed on October 1, 2020)lender
   
31.1+ Certification of ChiefPrincipal Executive Officer
   
31.2+ Certification of ChiefPrincipal Financial Officer
   
32.1+ Section 1350 Certification of ChiefPrincipal Executive Officer
   
32.2+ Section 1350 Certification of ChiefPrincipal Financial Officer
   
101.INS XBRL Instance Document
   
101.SCH XBRL Taxonomy Extension Schema Document

101.CAL XBRL Taxonomy Extension Calculation Linkbase Document
   
101.DEF XBRL Taxonomy Extension Definition Linkbase Document
   
101.LAB XBRL Taxonomy Extension Labels Linkbase Document
   
101.PRE XBRL Taxonomy Extension Presentation Linkbase Document

 

+Filed herewith.

 


Signatures

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

 

 Summer Infant, Inc.
   
Date: November 10, 2020May 18, 2021By:/s/ Stuart Noyes
  Stuart Noyes
  Interim Chief Executive Officer
  (Principal Executive Officer)Officer and Director)
   
Date: November 10, 2020May 18, 2021By:/s/ Edmund SchwartzBruce Meier
  Edmund SchwartzBruce Meier
  Interim Chief Financial Officer
  (Principal Financial and Accounting Officer)